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STOCHASTIC METHODS IN MODELING THE IMMUNE RESPONSE
Saishuai Tang, PhD
University of Pittsburgh, 2010
We discuss the application of deterministic and stochastic modeling techniques to prob-
lems in immunology. First, we employ the example of a host response to influenza virus
infection to illustrate differences in the dynamical behavior of the deterministic and the
stochastic models, and employ both versions in the analysis of the role of immune response
in controlling and suppressing the infection. Second, we develop a dynamical model of vo-
cal fold inflammation and use random sampling techniques to calibrate the model against
available data.
In the stochastic model, we analyze three solution techniques - Gillespie’s stochastic sim-
ulation algorithm, numerical solution of mean extinction time through the Laplace transform
of the master equation, and approximate solution of a limiting case. Gillespie algorithm is
capable of dealing with large systems as the required memory depends linearly on number of
species, but is limited by computational time. Laplace’s method is efficient and accurate but
is limited by system size. We construct a novel combination of the two that takes advantage
of both. We also derive an approximate Markov chain of the system and analytically compute
the extinction times and probabilities in the limiting case when an infected cell generates
large number of viruses. In the analysis of the human immune response, we find that innate
response substantially reduces cell extinction probability, cellular response increases the virus
extinction probability in limiting case, and adaptive response, combined with the other two,
almost eliminates cell extinction and significantly increases virus extinction probability.
In the model of vocal fold inflammation, a four-variable ordinary differential equation
iv
(ODE) model is presented. The ODE model characterizes cytokine interactions in phono-
trauma and is calibrated with empirical data. Parameter values are estimated and their
probability densities are sampled using Metropolis and parallel tempering algorithms. Sen-
sitivity analysis showed that 6 of 17 parameters suffice to retain the sensitivity of the model
trajectories. The reduced parameter set is applied to individual data to be calibrated and
predict the individual outcome. The model is a part of larger study intended to find optimal
treatment strategy for phonotrauma through a personalized vocal exercise or rest program.
Keywords: Stochastic Simulation Algorithm, Gillespie’s Direct Method, Markov Chain
Analysis, Numerical and Analytical Solution of Master Equations, Extinction Proba-
bility, Mean Extinction Time, Roles of Immune Components, Influenza Virus Infection,
Vocal Fold Inflammation, Parameter Estimation and Reduction, Sensitivity Analysis,
Metropolis Sampling, Parallel Tempering, Personalized Treatment Development.
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1.0 INTRODUCTION
In the first part of this thesis, we discuss a model of the immune response to influenza
infection. The human immune response to influenza A virus infection follows three distinct
strategies aimed at reducing the level of the virus and the amount of damage to the system
through negative feedback. The first strategy is the innate immune response, which renders
a portion of epithelial healthy cells resistant to infection. The second strategy is the cellular
immune response, which produces effector cells that destructs virus infected cells. The third
strategy is the adaptive immune response, which produces antibodies that inactivate the virus
particles. Each of the strategies represents a negative feedback on the virus production.
Mathematical modeling has proven to be a valuable tool in understanding of immune
response to influenza infection, primarily with ODE models [3, 40]. In the deterministic
model, the dynamics of the system are entirely predictable if sufficient knowledge of the
system states is given. But due to the stochastic nature of the system, this prediction might
not be true in certain situations. A stochastic model is a tool for estimating probabilistic
potential outcomes by allowing for random variation in the inputs over time. It builds
randomness into the simulation and therefore provides a better representation of real life.
This thesis is concerned with the development of a stochastic model of the immune response.
We first investigate a basic system of viral reproduction in the absence of any immune
component. We design a stochastic model of the system and compare its behavior with
a traditional ODE model. Three methods are utilized in analysis of the stochastic model:
Gillespie’s stochastic simulation algorithm [30], which is an exact procedure for simulating
the time evolution of a well-stirred chemically reacting system, solution of mean extinction
time through the Laplace transform of its master equation [67], which provides us explicit
formulas of mean extinction time, and approximate solution in the limiting case of large
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infectivity, which presents the analytical solutions when a single infected cell generates a
large number of viruses. We then extend the stochastic model to include various immune
system components. Our goal is to investigate the role of each feedback by studying its effect
on the global stochastic dynamics of the virus-cell system.
In the second part of this thesis, we discuss a model of vocal fold inflammation. When
people speak or sing, vocal folds are exposed to nearly continuous bio-mechanical stress - the
vocal folds oscillate at a relatively high frequency and typically make contact at some point
during the vibratory cycle. When the phonation conditions are phonotraumatic, increased
intra-fold contact stress associated with certain voicing patterns can result in structural dam-
age to the vocal fold mucosa [80, 37, 38]. If this condition persists without adequate rest,
the persistent stress can further lead to tissue disorganization [36]. Traditionally, behavioral
voice treatment involves complete or partial voice rest with the aim that the ensuing inflam-
matory response will subside on its own. However, recent data derived from concentrations
of inflammation mediators in laryngeal secretions suggests that some forms of vocal fold tis-
sue mobilization, i.e. resonant voice, may be able to modulate the inflammatory and healing
process [53, 51].
In this thesis, a dynamic model is developed to characterize the process of vocal fold in-
flammation after phonation loading. Ensemble modeling technique is employed to estimate
the parameter values and sample their probability densities. The number of independent
parameters of the model is reduced through sensitivity analysis. We also conduct parameter
reduction and employ the reduced model in prediction of the individual treatment outcome.
The research reported here is a part of a larger project aimed in developing tools to help
clinicians to decide which treatment benefits individual patients with acute or chronic phono-
trauma through a personalized vocal exercise or rest program.
2
2.0 IMMUNE RESPONSE TO INFLUENZA INFECTION
2.1 INTRODUCTION
2.1.1 Deterministic and Stochastic Models
Systems biology employs primarily two types of models: deterministic and stochastic. In
a deterministic model, the dependent variables usually represent concentrations of cells or
chemicals and a set of ODEs or PDEs governs the evolution of the system. Such models tend
to be accurate in the limit of large system size for well-mixed conditions. In a stochastic
model, variables represent numbers of molecules or cells, and the evolution of the system is
represented by a stochastic process described by a master equation. One important difference
between the two models is the presence or absence of absorbing states. There are situations
in which the deterministic model predicts that a population approaches a positive stationary
level, while the stochastic model predicts that an extinction will occur with certainty. In
such situations, one may ask the following questions:
• How to determine the probability of extinction and characterize the time required for
the extinction?
• Does a bifurcation in the deterministic model correlate with a change in the behavior of
the stochastic model?
The mean extinction time can be found if we can solve the master equations, but this is
known to be surprisingly difficult. The analysis of the mean extinction time in the context
of population class models has been discussed by several authors. Newman [67] and Nasell
[66] presented the analysis of mean extinction time of a stochastic version (logistic stochastic
model) of the Verhulst deterministic model [87] - a finite-state birth and death process
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with an initially modest number of individuals, no immigration nor emigration, and one
absorbing state. Vellela and Qian [83] presented a model with 3 species and 3 reactions with
one absorbing state, but they enumerated the states according to one species, so it is still
equivalent to the one dimensional logistic stochastic model. Nasell [65] also presented the
mean extinction time analysis in a two-dimension model - the stochastic version of the SIR
model (a model with three classes, susceptible, infected, and recovered, in a fixed population)
and found that the mean extinction time is an exponential distribution with a finite expected
value. There are also other discussions of the mean extinction time in the stochastic SIR
and SIS (a model derived from the SIR model by simply considering that the individuals
recover with no immunity to the disease, that is, individuals are immediately susceptible
once they have recovered) models by Nasell [64], Dykman [24] and Kamenev [46]. In the
two-dimension case, most of these papers analyzed the extinction time approximately in
different parameter regions through a variety of mathematical techniques. Nasell [66] states
that it is impossible to find explicit expression for the time to extinction of a stochastic model
whose deterministic counterpart is nonlinear. Few papers discuss the extinction probability.
Herwaarden [82] derive an asymptotic expression for the disease extinction probability at
the end of a major outbreak in the two-dimension stochastic SIR model. The expression is
derived by asymptotically solving a boundary value problem on the Fokker-Planck equation
of the system.
In this thesis, we present a stochastic model derived as a model of virus dynamics in a
host individual. First, we simulate system behavior through Gillespie’s direct method, then
we derive formulas of extinction time moments through the analysis of the Laplace transform
of the master equation [67]. The Laplace transform converts the nonlinear master equation
into a system of linear algebraic equations, which we can solve numerically to get the mean
and variance of the extinction time. The model can also be approximated by a reduced
Markov chain in one dimension with two absorbing states. We derive analytical expressions
of both mean extinction time and probability of such a reduced chain.
4
2.1.2 In-host Virus Dynamics
In mathematical modeling of virus dynamics, ODE models of within-host viral infections
of target cell populations were developed by Perelson and Nelson [71], Nowak and May
[69] and others [61, 68, 72]. These models were primarily derived for HIV infection, and
later applied to other viral infections [69]. They focused on the disease dynamics within
an infected individual and provided the quantitative understanding of the level of virus
production during infection [50, 72].
Leenheer and Smith [50] presented a global analysis of virus infection in an ODE model.
In the absence of any immune component, the system follows a limit cycle trajectory that
traverses through a region of almost complete absence of healthy cells, marked by a high pro-
portion of infected and damaged cells. Bifurcation analysis of a complete immune response
model, developed by Hancioglu [40], shows that the innate response, which renders a portion
of healthy cells resistant to infection, eliminates this limit cycle and, instead, causes the
system to converge to a chronic state with finite proportion of healthy and infected cells and
virus level. The cellular response, which produces effector cells to remove the virus infected
cells, lowers the magnitude of damage in the chronic state and, for some virus concentra-
tions, causes the trajectory to pass very close to the healthy state. Finally, the adaptive
response, which produces antibodies to neutralize viruses, stabilizes the healthy steady state
as a global attractor of the system. (Unpublished results of M. Goldrich and D. Swigon).
Here we analyze the role of each immune component using a stochastic model, with the
following questions in mind:
• Is any type of the immune component, by itself, able to clear virus and stabilize the
healthy state?
• Can any type of the immune component be eliminated or weakened without disrupting
the function of the immune system?
• Can any type of the immune component be enhanced and take over another type’s role?
If the answer is negative to all these questions, we must conclude that the immune
system is optimally designed for clearance of viral infection. To assess the effect of individual
components of the immune system, we shall focus on two variables - the total damage to
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the system, expressed as the proportion of cells incapable to perform their function, and
the total amount of virus in the system. We shall also be interested in finding out how
the systemic response depends on parameters describing the strength of the virus and the
strength of each immune strategy.
2.2 BASIC SYSTEM
In the absence of immune response, the system consists of three components - the free
virus particles (V), the healthy (susceptible) cells (H) and the infected cells (I). The most
appropriate model of viral infection is a combination of a predator-prey model (with healthy
cells as a prey and virus as the predator) and SIS epidemiological model. Neither of these
models is correct in isolation. The classical predator-prey model predicts an unlimited growth
of the prey in the absence of a predator, although in reality the amount of healthy cells should
not exceed a limiting threshold. The SIS model would describe the situation in which the
rate of infection of new individuals (cells) is proportional to the amount of infected cells,
while during viral attack it should be proportional to the amount of free virus.
Healthy
H
IAV
V
Infected
I
Dead
D
Figure 1: Basic System
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2.2.1 ODE Model
ODE model based on the diagram in Figure 1 can be presented by the following system
of differential equations:
V˙ = γV I − γV HHV − aV V (2.2.1)
H˙ = bHD(1− I −H)H − γHV V H (2.2.2)
I˙ = γHVHV − aII (2.2.3)
Here, the virus particles are produced in infected cells with about n = γV H/aI particles
released upon the death of a single infected cell. The virus particles infect healthy cells and
turn them into infected cell, with circa m = γV H/γHV virus particles necessary to infect a
single health cell. The virus level also naturally decreases with k = aV /γV H being the average
amount of viral particles decayed before one infected cell is produced. All the variables are
re-scaled by the homeostatic level H∗ = 1012 cells. H and I are given as proportions of H∗
and hence range from 0 to 1, and V is given as the amount of viral particles per infected
cell. The healthy cells regenerate with a rate proportional to the quantity D = 1 − I −H ,
which may be called the damage.
Equation (2.2.2) describes that the regeneration of healthy cells depends on the system
being modeled. In the case of influenza, we use the following reasoning: The cells being
infected by influenza are epithelial cells of the respiratory tract. The human body contains
regulatory mechanism that strives to maintain a homeostatic level of such cells. Both the
infected and healthy cells count toward this level and hence healthy cells will regenerate
only if the total amount is below this homeostatic level. Other possibilities include a simpler
logistic term bHD(1 − H)H or a more sophisticated bHD(1 − D − I − H)H in which dead
cells are removed at a constant rate.
The analysis of influenza in humans [40] yielded the following estimates for the parameters
of the dimensionless model: γV = 510, γV H = 1.02, aV = 1.7, bHD = 4, γHV = 0.34, aI = 1.5.
(In the stochastic model described later, we shall assume for simplicity γV H = γHV = 0.7
and hence m = 1.) These constants correspond to roughly 340 (n = γV /aI = 510/1.5 = 340)
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virus particles released from an infected cell per day and one infected cell produced after
about 5 (k = aV /γHV = 1.7/0.34 = 5) virus particles decay.
The parameter γV describes the reproductive ability of the virus and is the main virus-
dependent parameter affecting the behavior of the system equation (2.2.1). Figure 2 and 3
show the dependence of the behavior of the system on γV .
When γV is less than the critical value γ
BP
V = (γV H + aV )aI/γHV , then the system has
a stable equilibrium state (V,H, I) = (0, 1, 0), which we call healthy state, and an unstable
equilibrium state (V,H, I) = (0, 0, 0), which we call dead state. When γV is above γ
BP
V , the
healthy state becomes unstable and the system has an additional steady state, which we call
chronic state. The chronic state is stable and is characterized by nonzero values of V and I
that depend on γV :
HC =
aV aI
γV γHV − γV HaI (2.2.4)
VC =
bHD(1−HC)
γHV (1 + bHDHC/aI)
(2.2.5)
IC =
γHV
aI
HCVC (2.2.6)
In equation (2.2.4), γV γHV − γV HaI > γBPV γHV − γV HaI = aV aI . Thus we have 0 <
HC < 1. When γV above γ
HB
V , the chronic state becomes unstable and a limit cycle appears
through a Hopf bifurcation. The limit cycle persists in the limit as γV →∞, but approaches
exponentially close to the dead state, which remains unstable for all values γV . See the
bifurcation diagram in Figure 2 and Figure 3.
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Figure 2: Bifurcation diagram of the basic system - virus dependence on γV and n. n = γV /aI
represents the number of viruses generated by a single infected cell. The system has different
behaviors through 3 parameter regions.
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Figure 3: Bifurcation diagram of the basic system - healthy cell dependence on γV and n.
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A standard course of infection starts in the vicinity of the healthy state with no infected or
dead cells and a small amount of the virus. We typically use (V (0), H(0), I(0)) = (0.03, 1, 0)
as the initial state in the ODE model. In the limit cycle regime, this trajectory rapidly
approaches a limit cycle that can be divided roughly into three periodically repeating parts:
(i) rapid growth of the number of infected cells and the number of viral particles until
exhaustion of healthy cells, followed by (ii) decay of infected cells with slowing production
and decay of the virus, (iii) regeneration of the healthy cells.
One important unrealistic feature of the basic ODE model is that the system is able
to make a recovery even after almost complete absence of healthy cells. This result is an
oversimplification: if we considered the cells to be a part of an organism, then the absence
of healthy cells would result in a systemic failure and death of the organism. In our case
we may pronounce the system dead if the number of healthy cells drops below a certain
threshold, say 0.1. Of course, the choice of that threshold will affect the outcome. This
problem results from the stochastic nature of the underlying problem and can be addressed
in the context, which we do below.
2.2.2 Stochastic Model
The set of interactions between free virus particles (V), the healthy (susceptible) cells (H)
and the infected cells (I) can also be written conveniently as a system of chemical reactions
that symbolically describes the interactions between the components. The reaction network
of the basic system is:
V +H
γV H−−→ I (2.2.7)
I
aI−→ nV +D (2.2.8)
V
aV−→ ∅ (2.2.9)
H +D
bHD−−→ 2H (2.2.10)
A single infected cell produces n numbers of viruses. n = γV /aI can be derived from
(2.2.1) and (2.2.3). The healthy cells regenerate with a rate proportional to the quantity
D = H∗ − I − H . These chemical reactions give rise to the system of equations (2.2.1) ∼
10
(2.2.3) under the assumption of mass-action kinetics, with one exception: for simplicity we
assume that the rate γHV is equal to γV H and hence m = 1. (Distinct values can be achieved
by adding the reaction V +H
γHV −γV H−−−−−−→ H describing inefficient infection.)
The reactions (2.2.7) ∼ (2.2.10) imply that the total number H∗ = H +D + I of cells
is invariant and hence the phase space is a semi-infinite triangular prism bounded by the
planes H = 0, I = 0, H + I = H∗, and V = 0, with D = H∗ − H − I. Both the healthy
state (V,H, I) = (0, H∗, 0) and the dead state (V,H, I) = (0, 0, 0) are absorbing states. The
dead state (0, 0, 0) lies in the invariant facet of the phase space for which H = 0 - the green
plane in Figure 4. Once a trajectory enters this facet, it will converge toward (0, 0, 0), and
this convergence will be monotonic in I . The healthy state (0, H∗, 0) lies on the invariant
line V = I = 0 , the red line in Figure 4 - once a trajectory enters this line, it will converge
toward (0, H∗, 0), and this convergence will be monotonic in H .
V
V
max
0
I
HH∗
Figure 4: V-H-I triangular prism. The red line is the absorbing region for healthy state and
green plane is the absorbing region for dead state .
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The master equation for the reactions (2.2.7) ∼ (2.2.10) is given by:
d
dt
PV,H,I(t) = γV H(H + 1)(V + 1)PV+1,H+1,I−1(t) + aI(I + 1)PV−n,H,I+1(t)
+aV (V + 1)PV+1,H,I(t) + bHD(H − 1)(H∗ −H − I + 1)PV,H−1,I(t) (2.2.11)
−(γV HHV + aII + aV V + bHDH(H∗ −H − I))PV,H,I(t)
This equation is actually a system of ordinary differential equations that describes the
occupancy probability for different states of a chemical system during a Markov process. It
is also called a Kolmogorov equation. Each molecular species in the chemical model adds a
dimension to the state space. Unfortunately, the master equation (2.2.11) is too complex to
solve explicitly. So we have solved (a) the mean and limiting extinction probability of the
system; (b) the conditional mean, variance and coefficient of variation of extinction times,
of both viruses and healthy cells through the following method:
• Exact stochastic simulation - simulate the reaction network through Gillespie’s direct
method [30, 31].
• Numerical solution of the moments of extinction times through the Laplace transform of
the master equations [67].
• Approximately analytically solution of the master equation in the limit of n→∞.
2.2.2.1 Stochastic Simulation Algorithm The most common method for solving a
master equation in systems biology is a stochastic simulation algorithm (SSA) [30, 31, 29].
SSA is an essentially exact procedure for numerically simulating the time evolution of a well-
stirred chemically reacting system. It is derived rigorously based on the same microphysical
premise that underlies the chemical master equation [60, 32]. So it is logically equivalent
to the master equation. The simulation statistically realizes the underlying Markov pro-
cess. The trajectories of species in the model are simulated by randomly applying reactions.
Many statistical properties of the system, such as the extinction time moments, probability
distribution, etc., can be computed through SSA.
Gillespie [30] proposed two mathematically equivalent methods for implementing the
SSA, namely the direct method (DM) and the first reaction method (FRM). DM is much
12
more efficient than FRM and it the most commonly employed method. A third formulation
of SSA is the next reaction method (NRM) by Gibson and Bruck [29] published in 2000.
NRM is an extension of FRM and it is significantly faster than FRM. It is also faster than
DM under certain conditions - when many species and reaction channels are involved and
the system is loosely coupled. But this statement is argued by Cao and his co-workers [10]
who claimed that NRM was more efficient than the DM only in a very specialized class of
problems. Simulation methods that are more efficient, but not exact, have been recently
proposed, such as explicit [35, 8, 9] and implicit [75] τ -leaping method, optimized direct
method [10]. A recent paper of Gillespie [34] contains a review of the relevant work in this
fields in the past 30 years. Here, we illustrate the DM algorithm and briefly discuss the other
methods.
Suppose we have M reactions, R1, R2, ..., RM , in total. Define the following variables
at time t [30, 47].
• Cµ: the rate of reaction Rµ.
• hµ: the number of reactant combinations for reaction Rµ.
• aµdt = hµCµdt: probability that reaction Rµ occurs in the next time interval dt.
• a0dt =
∑M
µ=1 aµdt: the sum of the average probabilities that any reaction occurs in the
next time interval dt
• P0(τ): probability that no reaction occurs during (t, t + τ)
• P (τ, µ)dτ = P0(τ)hµCµdτ : probability at time t that the next reaction is Rµ and occurs
in the interval (t+ τ, t+ τ + dτ). So P (τ, µ) is the reaction probability density function.
For example, if reaction R1: A+B → AB occurs and the number of molecules A and B
are X and Y , then h1 = XY and a1 = XY C1.
Divide the time interval (t, t+ τ) into K subintervals with width ε. The probability that
none of the reactions occurs in the N subintervals is:
P0(τ) =
(
1−
M∑
i=1
hiCiε
)K
= lim
K→∞
(
1−
∑M
i=1 hiCiτ
K
)K
= e−
∑M
i=1 hiCiτ = e−a0τ (2.2.12)
Then
P (τ, µ) = P0(τ)hµCµ = e
−a0τaµ = (a0e
−a0τ )
(
aτ
a0
)
= P (τ)P (µ | τ) (2.2.13)
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Here P (τ) represents when next reaction occurs and P (µ | τ) reperents which reaction
occurs. We need to generate two random numbers r1 and r2, which are uniformly distributed
on [0, 1]. Then,
e−a0τ = r1 ⇒ τ = (1/a0) ln(1/r1) (2.2.14)
and µ is the integer for which
µ−1∑
i=1
ai
a0
< r2 <
µ∑
i=1
ai
a0
(2.2.15)
Figure 5: Scheme of the Gillespie’s direct method [47]
Here is the pseudo algorithm of Gillespie’s direct method:
1. Initialization:
- Set initial numbers of molecules and time t = 0.
- Set values of Cµ for the M reactions.
2. Calculate the values of ai and a0 =
∑M
i=1 ai.
3. Generate the two uniformly distributed random numbers r1 and r2;
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- Set τ = (1/a0) ln(1/r1)
- Set µ to the integer that satisfies:
∑µ−1
i=1 ai/a0 < r2 <
∑µ
i=1 ai/a0.
4. Change the number of molecules to reflect the execution of reaction µ.
5. Increase time t by τ .
6. Return to step 2 until total simulation time t reaches target maximum time.
In each loop, DM generates two random number in equation (2.2.14) and (2.2.15). In
the algorithm of FRM, it generates a τk for each reaction channel Rk according to τk =
(1/ak) ln(1/rk), where k = 1, ...,M , and r1, ...rM are statistically independent samplings
from the unit interval. Then τ = min{τ1, ...τM} and µ is the index of themin{τ1, ...τM}. The
improvement of NRM is that NRM reuses theM−1 unused randomly generated numbers in
FRM and generates a new random number to replace the used one, then carefully updates the
system to choose the next reaction. Clever data storage structures are employed to efficiently
find τ and µ. The DM, FRM and NRM all produce exactly realizations of molecules by
generating random pairs (τ, µ) rigorously according to the joint density function (2.2.13).
The three methods can therefore be regarded as mathematically equivalent. NRM is widely
believed to be more efficient than DM because it only generates one random number per step
while DM generates two. But NRM has extra cost in its special data structures. Cao [10]
tested the two algorithms on several systems and found NRM not as efficient as DM most
of the time. Then they proposed a method called optimized direct method by re-indexing
the reaction channels in a large system. The simulation time is speeded up by 12% - 25 %
by Cao’s result.
In our model, we choose the DM implementation of the SSA to simulate our system.
All the algorithms are implemented in MATLAB 7.5.0 (R2007b). In order to speed up the
simulation, we utilize the powerful feature of matrix computation in MATLAB and wrote
the code in such a way that hundreds of independent trajectories can be simulated in a single
loop. This increased simulation speed by a factor of 10 ∼ 50 compared with a program in
which the trajectories are simulated consecutively. We have studied the system behavior
for various values of n at several different system sizes. The system with H∗ = 100 and
with initial condition (V0, H0, I0) = (0.03H
∗, H∗, 0) is the most common system size we have
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studied because of its reasonable simulation time. We focus our attention on the following
characteristics of the system:
Definition 2.2.1. Conditional mean extinction time, defined as the mean cell or virus
extinction time over trajectories in which cell or virus extinction occurs.
Definition 2.2.2. Extinction probability, defined as the probability of cell or virus ex-
tinction.
Definition 2.2.3. Limiting extinction probability, defined as the limit of cell or virus
extinction probability as n→∞.
Results: Figure 6 shows the sample trajectories of the system produced by Gillespie’s
direct method. The trajectories can be divided into three distinct types, depending on
whether they terminate in healthy state (type I), dead state (type II), or they persist without
termination (type III).
For small values of n, essentially all trajectories are of type I. At some intermediate values
of n, roughly corresponding to the values of γBPV < γV < γ
HB
V , almost all the trajectories
are type III. At large values of n, most trajectories are of type II . Once a typical trajectory
visits the neighborhood of the invariant facet H = 0 before visiting the neighborhood of the
line V = I = 0, it is likely to be captured by the dead state.
In Figure 6, the initial number of healthy cells, viruses, and infected cells are H0 = H
∗ =
100, V0 = 3, and I0 = 0. The other parameters are n = γV /aI = 15 and maximum simulation
time Tmax = 30. The reaction rates used in the simulation are referred from Hancioglu’s
paper [40], aI = 1.5, aV = 1.7, γV H = 0.7/H
∗, bHD = 4/H
∗ (Some of the parameters are
adjusted by the homeostatic level in our Gillespie algorithm).
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Figure 6: Sample trajectories of the basic system obtained by the Gillespie’s direct method.
H0 = H
∗ = 100, V0 = 3, I0 = 0, n = 15, Tmax = 30, number of the trajectories=30.
For comparison, we have run the ODE model and Gillespie simulation together by using
the same parameter values (see Figure 7). We set γV = 40, so n = γV /aI = 27, and
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Tmax = 30. The trajectories of ODE model are showed in the first row subplots. We can see
the limit cycles in the H − V and I − V planes. Healthy cells H are always able to recover
from an almost complete absence. The trajectories in the second row are derived from a
single simulation using Gillespie’s direct method. We can see that when healthy cells drop
below a certain level, they try to recover, but after small excursion they go to extinction at
t ≈ 6. After healthy cell extinction, the infected cell is extinct at t ≈ 7, and then followed
the virus extinction at t ≈ 8. The green dots in the plots are where the first extinction -
healthy cell extinction in this sample - occurs.
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Figure 7: Trajectory comparison for ODE and stochastic models of the basic system. Pa-
rameters are equivalent in the two models. (V0, H0, I0) = (0.03, 1, 0) in the deterministic
model and (V0, H0, I0) = (3, 100, 0) in the stochastic model. γV = 40, n = 27, Tmax = 30.
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In Figure 8, we plot the conditional mean extinction times and extinction probabilities
as functions of n. As we mentioned before, the stochastic model shows three kinds of
behavior in the different parameter regions. When n < 6, no cell extinction occurs. When
6 ≤ n < 11, a few cell extinctions occurs and the conditional mean time of cell extinction
increases dramatically. When 11 ≤ n < 25, the cell extinction probability increases fast to a
limiting probability PC = 0.64, and remains at that level as n→∞. At the same time, the
conditional mean cell extinction time gradually decreases to a certain level. For the viruses,
it has an almost complete extinction with probability 1 when n is small, decreases fast when
n < 10, and gradually decreases to a limiting probability PV = 0.36 when n > 10. The
conditional mean virus extinction time has a peak at around n = 5, where the cell extinction
starts to appear, and then it decreases fast at 5 ≤ n < 10 and reach a limiting extinction
time when n > 25.
We have examined the effect of simulation time on the results when Tmax = 10, 20, 30, 40, 50, 60,
and define the non-extinction as neither cell nor virus extinction occurs when the simu-
lation time reaches Tmax. In Figure 8, the trajectories of conditional extinction time and
extinction probability at different Tmax are the same before the bifurcation and at the lim-
iting case. The larger Tmax, the faster the system reaches the limiting or stable level. As
expected, the peaks of the cell and virus conditional extinction time always occur at the
same n intervals and become higher as we increase the simulation time. According to Figure
8, it appears that there might be an explosion of the extinction time at some certain values
of n. Below we verify that such an explosion does not happen, i.e., the mean extinction time
is finite, using the Laplace transform method.
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Figure 8: Conditional mean time and probability of extinction with different maximum
simulation times, Tmax = 10, 20, 30, 40, 50, 60, H
∗ = 100, V0 = 3. The x-axis represents n
values and the y-axis represents conditional mean extinction time in the first row plots and
extinction probability in the second row plots. All the trajectories are averaged over 50,000
independent samples.
2.2.2.2 Numerical Solution of Mean Extinction Time The master equation for the
system (2.2.7)-(2.2.10) was given in (2.2.11). It is too complex to be solved analytically, but
it can be solved numerically if the state space is truncated at an upper limit of the copy
number in each species. In fact, since the total number of cells is limited by H∗, one only
needs to truncate the number of virus particles. An artificial boundary condition P (x, t) = 0
is usually added at xi > xmax for a sufficiently large xmax > 0 to obtain a finite computational
domain.
20
H − I Plane
I
H
Enumerate
Imax=H∗
H∗Dead StateH=V=I=0
Healthy State
H=H∗, V=I=0
Figure 9: Enumerating the states on H − I plane
We truncate the state space at an upper limit Vmax of the copy number of viruses.
Variables H , I, D are bounded by the equation H + I +D = H∗. The remaining problem
would be how to enumerate all the states in the truncated system. Figure 9 shows our
method to enumerate the states on H − I plane. We are going to enumerate all the states
H − I plane by H − I plane according to different number of viruses. We start at the H − I
plane with V = 0. The dead state (V,H, I) = (0, 0, 0) is the first state, (V,H, I) = (0, 0, 1)
is the second state, then (V,H, I) = (0, 0, 2) is the third state and so on. The healthy
state (V,H, I) = (0, H∗, 0) is the last state on the first plane (V = 0). Then we continue
enumerating on the second H − I plane with V = 1, and then the third plane with V = 2
till V = Vmax. The total number of states is:
N = (H∗ + 1)(H∗ + 2)(Vmax + 1)/2 (2.2.16)
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If we take H∗ = 100, Vmax = 600, the system size is approximately 3 × 106. It is still
so large that it is not possible to solve the master equation using numerical ODE solvers.
Fortunately, there is a way to compute exactly the mean extinction time and other moments
by using Laplace transform of the master equation [67].
Here is how we implement the method for our model. First, each Pi corresponds to a
PV,H,I with V , H , I being a certain number. P1, P2, P3, ..., PTotalPoint denote the probability
at each state. PH , PD are the total probabilities of states in healthy absorbing region
(V = I = 0, H > 0, red line in Figure 4) and dead absorbing region (H = 0, green plane in
Figure 4). So we have:
PH =
H∗∑
H=1
P0,H,0 (2.2.17)
PD =
Vmax∑
V=0
H∗∑
I=0
PV,0,I (2.2.18)
The probability for the system to go to healthy absorbing states in a small time interval
δt is PH(t+ δt)−PH(t). Shrinking this time interval to zero, we have the distribution of the
extinction time:
dPH
dt
= lim
δt→0
PH(t + δt)− PH(t)
δt
(2.2.19)
From (2.2.11), we know
H∗∑
H=1
dP0,H,0
dt
=
H∗∑
H=1
(
aV P1,H,0(t) + bHD(H − 1)(H∗ −H + 1)P0,H−1,0(t)
−(bHDH(H∗ −H))P0,H,0(t)
)
(2.2.20)
=
H∗∑
H=1
aV P1,H,0(t) (2.2.21)
Thus the distribution of the virus extinction is simply:
dPH
dt
=
H∗∑
H=1
aV P1,H,0(t) (2.2.22)
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So the moments of the virus extinction time are obtained via
〈TV n〉 = av
∞∫
0
tn
( H∗∑
H=1
P1,H,0(t)
)
dt (2.2.23)
Similarly, the distribution of the cell extinction is
dPD
dt
=
Vmax∑
V=1
H∗−1∑
I=0
γV HV PV,1,I(t) (2.2.24)
The moments of the cell extinction time are obtained via
〈TCn〉 = γV H
∞∫
0
tn
( Vmax∑
V=1
H∗−1∑
I=0
V PV,1,I(t)
)
dt (2.2.25)
The Laplace transform of function P (t) is defined via
P̂ (s) =
∫ ∞
0
e−stP (t)dt (2.2.26)
and the transform of the derivative P ′(t) by∫ ∞
0−
e−stP ′(t)dt = s
∫ ∞
0−
e−stP (t)dt− P (0) (2.2.27)
The derivative of P̂ (s) with respect to s can be related to P (t) by
dnP̂ (s)
dsn
=
∫ ∞
0
(−t)ne−stP (t)dt (2.2.28)
Thus, can rewrite the moments equations in the following way:
〈TV n〉 = (−1)naV
H∗∑
H=1
dnP̂1,H,0(s)
dsn
∣∣∣∣
s=0
(2.2.29)
〈TCn〉 = (−1)nγV H
Vmax∑
V=1
H∗−1∑
I=0
V
dnP̂V,1,I(s)
dsn
∣∣∣∣
s=0
(2.2.30)
Now we are almost ready to calculate the moments of extinction times. The difficulty
of solving the master equation is the huge system size of (2.2.11). Our plan is to transform
the master equation (2.2.11) into a linear system through its Laplace transform, then solve
the linear system, and substitute the solutions in to equations (2.2.29) and (2.2.30) to get
the values of moments generating function. Apply (2.2.26) and (2.2.27) to the right and left
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sides of (2.2.11) separately. The Laplace transform of the master equation (2.2.11) is the
following system of algebraic equations:
sP̂V,H,I(s)− PV,H,I(0) = γV H(H + 1)(V + 1)P̂V+1,H+1,I−1(s) + aI(I + 1)P̂V−n,H,I+1(s)
+aV (V + 1)P̂V+1,H,I(s) + bHD(H − 1)(H∗ −H − I + 1)P̂V,H−1,I(s)
−(γV HHV + aII + aV V + bHDH(H∗ −H − I))P̂V,H,I(s)
(2.2.31)
Equation (2.2.31) is a linear system for any value of s. Let’s set s = 0 and denote it as
the following.
B0 = AP̂V,H,I(0) (2.2.32)
The initial condition of (2.2.32) is PV0,H∗,0(0) = 1 and PV,H,I(0) = 0 for all other states.
B0 = −PV,H,I(0) and A is the coefficient matrix of the right hand side of the system(2.2.31).
Equations (2.2.29) and (2.2.30) tell us that the moments of the extinction time depend on
the derivatives of the P̂V,H,I functions. By taking the derivative of (2.2.31) with respect to
s we obtain
P̂V,H,I(s) + s
dP̂V,H,I(s)
ds
= γV H(H + 1)(V + 1)
dP̂V+1,H+1,I−1(s)
ds
+ aI(I + 1)
dP̂V−n,H,I+1(s)
ds
+aV (V + 1)
dP̂V+1,H,I(s)
ds
+ bHD(H − 1)(H∗ −H − I + 1)dP̂V,H−1,I(s)
ds
−(γV HHV + aII + aV V + bHDH(H∗ −H − I))dP̂V,H,I(s)
ds
(2.2.33)
Set s = 0, equation (2.2.33) becomes a linear system again. Let us denote it as
B1 = A
dP̂V,H,I(0)
ds
(2.2.34)
Where B1 = P̂V,H,I(0), which can be solved from the linear system (2.2.32). By repeating
the above process one can obtain higher moments.
The results can be summarized in the following algorithm:
24
1. Solve the linear system (2.2.32) to get P̂V,H,I(0) .
2. Substitute the solutions of (2.2.32) into (2.2.34), and solve the system to get
dP̂V,H,I(s)
ds
.
3. Calculate the mean extinction time of virus through formula (2.2.29) by setting n = 1,
〈TV 〉 = −aV
H∗∑
H=1
dP̂1,H,0(0)
ds
∣∣∣∣
s=0
(2.2.35)
4. Calculate the mean extinction time of cell through formula (2.2.30) by setting n = 1,
〈TC〉 = −γV H
Vmax∑
V=1
H∗−1∑
I=0
V
dP̂V,1,I(s)
ds
∣∣∣∣
s=0
(2.2.36)
To calculate the second moments, take the second derivative of equation (2.2.31) and
set s = 0, we get
B2 = A
d2P̂V,H,I(0)
ds2
(2.2.37)
Where B2 = 2
dP̂V,H,I(0)
ds
, which is solved from the linear system (2.2.34). Similarly, solv-
ing the linear system (2.2.37) to get
d2P̂V,H,I(0)
ds2
and substitute the solution back to formula
(2.2.29) and (2.2.30) by setting n = 2 to get the second moments of the extinction times.
The variance of the extinction times is given by
V arV = 〈TV 2〉 − 〈TV 〉2 (2.2.38)
V arC = 〈TC2〉 − 〈TC〉2 (2.2.39)
and the coefficient of variation is given by
ρV =
√
〈TV 2〉 − 〈TV 〉2
〈TV 〉 (2.2.40)
ρC =
√
〈TC2〉 − 〈TC〉2
〈TC〉 (2.2.41)
To calculate the higher moments of extinction, we just need to continue taking derivatives
of (2.2.31) and solving the new linear system by substituting solutions from the previous
step.
We have mentioned before that the main advantage of the Laplace transform method
is to convert the nonlinear master equation into a linear system of algebraic equations.
Unfortunately, if we take H∗ = 100, Vmax = 600, the system size is approximately 3 × 106.
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Because of limited computer memory, we were not able to handle a system size as large as
3×106. We have explored several ways to improve the computational efficiency. Suppose the
system that we are going to solve is B¯ = A¯x¯. First, A¯ is a sparse matrix in our model. We
reorder the A¯ by Cuthill-McKee ordering [15] - a permutation such that A¯ tends to have its
nonzero elements closer to the diagonal. This reordering is very helpful in LU factorization.
We then use B = Ax to denote the new system. We divide the matrix A into 4 sub-matrices
with the same size, B into 2 vectors with same length and so does x. Then we have:
 B1
B2

 =

 A11 A12
A21 A22



 x1
x2

 (2.2.42)
That is
B1 = A11x1 + A12x2 (2.2.43)
B2 = A21x1 + A22x2 (2.2.44)
One can solve for x1 using
(A−112 A11 − A−122 A21)x1 = (A−112 B1 − A−122 B2) (2.2.45)
then substitute x1 into (2.2.43) and solve for x2. Each of the matrices in question has a lower
size than the original matrix A and hence they all fit in the computer memory. We apply
LU factorization whenever necessary into the intermediate matrices in above procedure.
This method help in improving the upper limit on the size of a solvable linear system in
MATLAB. It requires less memory when dealing with the inverse of these sub-matrices than
a full matrix. In the end, the largest size of the system that we were capable to solve was
H∗ = 25, Vmax = 181, corresponding to a total of 63882 states in the system.
Figure 10 shows the result of Laplace method. We have also applied the same parameter
set to Gillespie algorithm and plot the results of these two methods together. Notice that
equation (2.2.29) and (2.2.30) are formulas of mean extinction times. But what we have
calculated in the Gillespie’s direct method is the conditional mean extinction times. So we
need to apply the probability values at each n values derived from Gillespis algorithm to
(2.2.29) and (2.2.30) to get the conditional mean extinction time.
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Figure 10: Probability, conditional mean, variance and coefficient of variation of virus or cell
extinction. The red line is the result of Laplace method and the blue line is the result of
Gillespie’s direct method. V0 = 1, H
∗ = 25, Vmax = 181, all the other parameters are the
same as before. The x-axis is n = γV /aI .
This Laplace method only gives us the moments of the extinction times, not extinction
probabilities. The two plots in the first column in Figure 10 are the probabilities of virus
and cell extinction computed by the Gillespie’s method. The plots in the second column are
the conditional mean extinction times of the virus and cell. As we have pointed out before,
because of the limited simulation time, the peak in the Gillespie’s method is not accurate.
The plots in the third and forth column are the variance and coefficient of variation of virus
and cell. The y-axis of the plots are in log scale except ones in the first column. We see
that for n < 10, Laplace method generates much higher peaks than the Gillespie’s direct
method. When n > 10, the two methods coincide for the conditional mean extinction time
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of virus and have similar trajectories for the variance and coefficient of variation of virus
extinction. Because cell extinction is very sensitive to Vmax, the results of the two methods
for cell extinction time are similar only at some intermediate interval of n values.
From the computational side, Laplace method is faster than Gillespie’s direct method.
But the Gillespie’s method works better in the case of cell extinction than Laplace method
does, especially at high values of n where trajectories make excursions to high values of V .
When increased the system size, the variance of cell extinction in Laplace method became
negative at some values of n which implies that the system size has become to large to be
accurately computed by Laplace method. So Laplace method is accurate and efficient when
H∗ and n are small.
In summary, Gillespie’s direct method is limited by the simulation time and Laplace
method is limited by the system size, especially the cutoff value of Vmax. In order to take
the advantage of both methods, we combine the two methods to apply at different values of
H∗ and n.
2.2.2.3 Combination of Gillespie and Laplace Method In last section, we men-
tioned that the Laplace method is more efficient and accurate at small system size and when
n is small while Gillespie’s method is more accurate for large n. Figure 11 shows the result
of the combination of the two methods.
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Figure 11: A combination of Gillespie’s direct and Laplace methods. The red, dark blue,
green, light blue and pink trajectories represent (H∗, V0) = (5, 1), (10, 2), (15, 3), (20, 4), and
(25, 5) with Vmax = 181. The x-axis is n = γV /aI . Note the logarithmic scale of the ordinate
in the plots of extinction times, variances and coefficients of variation.
We have studied the dependence of extinction times on system size by using the follow-
ing values, (H∗, V0) = (5, 1), (10, 2), (15, 3), (20, 4), (25, 5). Vmax was fixed at 181. Figure
11 shows how the system size effect the results. The limiting probability of virus extinc-
tion decreases as we increase the system size while the limiting probability of cell extinction
increases.
In both Gillespie’s and Laplace’s methods, we find that the conditional extinction times
of both virus and cells grow exponentially with the system size. One dimensional models
studies by Nasell [66] and Vellela [83] agree with this result. In our model, the coefficient of
variation of virus extinction increases with the system sizes and reaches the maximum value
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at some intermediated n values. Newman [67] states in a one dimensional birth-death model
that the coefficient of variation is found to have a maximum value when the death and birth
rates are close in the value. These paper all discuss the extinction time in three parameter
regions: long, intermediate long and short extinction time. The second region is a transition
region between the other two.
2.2.2.4 Approximate Solution of a Limiting Case Recall from Figure 6 that there
is a special subset of trajectories which are of short duration and in which the number of
viruses never increases. In this section, we will show that these trajectories have the same
probability of occurrence independent of n and can be interpreted as no-disease trajectories.
We analyze them analytically using a corresponding Markov Chain.
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Figure 12: m is the initial number of viruses. 0, 1, 2, ..., m are the states representing
V = 0, 1, ...m and I = 0. m+ 1 represents all states with V > m or I > 0. The red dashed
ellipse denotes the no-disease region.
In Figure 12, numbers 0, 1, 2, ...,m represent the states (V,H, I) = (0, H∗, 0), ..., (m,H∗, 0)
of the system. Thus, the state 0 represents the healthy state. The state m+ 1 is outside of
the no-disease region with I > 0 or V > m (assume m < n). The only way for the system
to leave the no-disease region and enter state m + 1 is when reaction V + H → I occurs.
The only channel for the system to go from state m+ 1 back to no-disease region is that it
goes to state m first. Let’s denote this returning probability as ρn. State m has I = 0. So
I → nV +D must occur with probability 1 if the system is to go from m+ 1 back to state
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m. Once I → nV + D occurs, the system has ≥ n number of viruses, the probability for
these viruses to decay to number m is Pm+1−to−m =
(
aV
aV +γV H
)n−m
. So ρn ≤ Pm+1−to−m. As
n becomes large, we have:
0 ≤ lim
n→∞
ρn ≤ lim
n→∞
(
aV
aV + γV H
)n−m
= 0 (2.2.46)
Therefore, as n→∞, and limn→∞ ρn = 0, the basic system behaves as the Markov chain
in Figure 12. In the other word, as n→∞ the basic system will either stay in the no -disease
region, and converge to the healthy state, or it will leave the no-disease region and never
return to healthy state, as m + 1 becomes an absorbing state. The master equation of this
reduced model is below:
dPm+1
dt
= γV HP1 + 2γV HP2 + 3γV HP3 + · · ·+mγV HPm
dP0
dt
= aV P1
dP1
dt
= −(aV + γV H)P1 + 2aV P2
dP2
dt
= −2(aV + γV H)P2 + 3aV P3
... (2.2.47)
dPm−1
dt
= −(m− 1)(aV + γV H)Pm−1 +maV Pm
dPm
dt
= −m(av + γV H)Pm
We have employed two methods to solve the system (2.2.47).
Method 1: The Embedded Markov Chain
If the states of a Markov process are discrete and the process may change state at any
point in time, we say that the process is a continuous-time Markov chain (CTMC). If the
transitions between states is independent of time, it is called a homogeneous, continuous-
time Markov chain. Let q¯ij be the rate at which transitions occur from stat i to state j.
When the CTMC is homogeneous, the transition rates q¯ij are independent of time and the
matrix of transition rates can be written as Q¯. When discussing the Gillespie algorithm,
we have shown that the time spent by the system in any state is exponentially distributed.
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In a state i, the parameter of the exponential distribution of the sojourn time is given by
−q¯ii =
∑
j 6=i q¯ij. If we ignore the time actually spent in any state and consider only the
transitions made by the system, we may define a new, discrete-time, Markov chain called
the embedded Markov chain (EMC). Many of the properties of a CTMC can be deduced
from its corresponding EMC. For example, a CTMC is irreducible if and only if its EMC
is irreducible and a single state is recurrent in a CTMC if and only if it is recurrent in its
EMC [78].
For a CTMC the one step transition probabilities of its corresponding EMC, denoted by
qi,j, are given by
qij =
q¯ij∑
j 6=i q¯ij
, j 6= i
= 0, i = j (2.2.48)
Let Q denote the transition probability matrix of the EMC. All elements in Q satisfy
0 ≤ qij ≤ 1 and
∑
i,j 6=i qij = 1 for all i. Thus Q possesses the characteristics of a transition
probability matrix for a discrete-time Markov chain [78]. So the limiting probability can be
found as
P = lim
n→∞
P0Q
n (2.2.49)
where P0 is the initial probability distribution.
We shall use the EMC to find the limiting probability of virus extinction. Let’s start
with examples in which the initial number of viruses is 1 and 2.
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Case 1: m = 1
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Figure 13: State 1 is the initial state (V,H, I) = (1, H∗, 0), state 0 is the healthy state
(V,H, I) = (0, H∗, 0), and state 2 is the dead absorbing region I > 0 or V > 1.
State 2 represents the absorbing region outside of the no-disease region. State 0 is the
healthy state with (V,H, I) = (0, H∗, 0). State 1 is the initial state with (V,H, I) = (1, H∗, 0).
We shall reorder the states as (2, 0, 1) so that we can get the transition rate matrix in a good
permutation for computation, i.e., P = (P2, P0, P1). The transition probability matrix is:
Q1 =


1 0 0
0 1 0
γV H
aV +γV H
aV
aV +γV H
0

 (2.2.50)
and the initial state P (0) = (0, 0, 1). If we take Q1 squared, we find:
Q21 =
1
(aV + γV H)2


aV + γV H 0 0
0 aV + γV H 0
γV H aV 0


2
= Q1 (2.2.51)
Hence
Ql1 = Q
l−1
1 = . . . = Q
2
1 = Q1, l ≥ 1 (2.2.52)
So
P (0)Ql1 = (0, 0, 1)Q1 =
(
1− aV
aV + γV H
,
aV
aV + γV H
, 0
)
, l ≥ 1 (2.2.53)
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is the stationary state, which means that by the end the system has a probability of 1− aV
aV +γV H
to be a dead state and a probability of aV
aV +γV H
to be a healthy state if the initial number of
viruses is 1.
Case 2: m = 2
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Figure 14: State 2 is the initial state, state 0 is the healthy state, and state 3 is the dead
absorbing region.
Let P = (P3, P0, P1, P2). The transition probability matrix is:
Q2 =


1 0 0 0
0 1 0 0
γV H
aV +γV H
aV
aV +γV H
0 0
γV H
aV +γV H
0 aV
aV +γV H
0


(2.2.54)
and the initial state P (0) = (0, 0, 0, 1).
Calculate Q2 square,
Q22 =


1 0 0 0
0 1 0 0
1− aV
aV +γV H
aV
aV +γV H
0 0
1− ( aV
aV +γV H
)2 ( aV
aV +γV H
)2
0 0


(2.2.55)
Calculation of Q32, reveals that Q
3
2 = Q
2
2. Hence,
Ql2 = Q
l−1
2 = . . . = Q
2
2, l ≥ 2 (2.2.56)
34
So
P (0)Ql2 = (0, 0, 0, 1)Q
2
2 =
(
1− a
2
V
(aV + γV H)2
,
a2V
(aV + γV H)2
, 0
)
, l ≥ 2 (2.2.57)
is the stationary state, which means that by the end the system has a probability of 1 −(
aV
aV +γV H
)2
to be a dead state and a probability of
(
aV
aV +γV H
)2
to be a healthy state if the
initial number of viruses is 2.
On the basis of these two examples, we can deduce a general result.
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Figure 15: m is the initial number of viruses. 0, 1, 2, ..., m are the states representing the
number of viruses and I = 0. m+ 1 represents the states when V > m or I > 0.
Theorem 2.2.1. If the initial number of viruses is m and V + H
γV H−−→ I occurs, specifi-
cally when n → ∞, the system (2.2.47) has a stationary state with the probability of virus
extinction
PH =
( aV
aV + γV H
)m
(2.2.58)
and the probability of cell extinction
PD = 1−
( aV
aV + γV H
)m
(2.2.59)
The transition probability matrix Qm has the property
Qlm = Q
l−1
m = . . . = Q
m+1
m = Q
m
m, l ≥ m (2.2.60)
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where
Qmm =


1 0 0 · · · 0 0
0 1 0 · · · 0 0
1− aV
aV +γV H
aV
aV +γV H
0 · · · 0 0
1−
(
aV
aV +γV H
)2 (
aV
aV +γV H
)2
0 · · · 0 0
...
...
...
... 0 0
1−
(
aV
aV +γV H
)m−1 (
aV
aV +γV H
)m−1
0 · · · 0 0
1−
(
aV
aV +γV H
)m (
aV
aV +γV H
)m
0 · · · 0 0


(2.2.61)
Proof. We have verified this result for m = 1, 2. For m ≥ 3, we prove the result using
induction. Suppose it is true when V0 = m − 1, let’s consider the case of V0 = m. The
transition probability matrix Qm is a (m+ 2)× (m+ 2) matrix:
Qm =


1 0 0 · · · 0 0 0
0 1 0 · · · 0 0 0
γV H
aV +γV H
aV
aV +γV H
0 · · · 0 0 0
γV H
aV +γV H
0 aV
aV +γV H
· · · 0 0 0
...
...
...
... 0 0 0
γV H
aV +γV H
0 0 · · · aV
aV +γV H
0 0
γV H
aV +γV H
0 0 · · · 0 aV
aV +γV H
0


(2.2.62)
Divide matrix Qm into four sub-matrices,
Qm =

 A B
C D

 (2.2.63)
where A is a (m + 1) × (m + 1) matrix composed by the intersection of the first
m + 1 rows and m + 1 columns of Qm. B is a (m + 1) × 1 zero column vector. C =(
γV H
aV +γV H
, 0, 0, · · · , aV
aV +γV H
)
with size 1 × (m + 1). D is a 1 × 1 zero matrix. From the
construction of Qm, we can see that A = Qm−1. Then
Q2m =

 A B
C D



 A B
C D

 =

 A2 0
CA 0


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Q3m =

 A2 0
CA 0



 A B
C D

 =

 A3 0
CA2 0


. . . (2.2.64)
Qmm =

 Am−1 0
CAm−1 0



 A B
C D

 =

 Am 0
CAm−1 0


We have A = Qm−1, so A
m = Qmm−1 = Q
m−1
m−1 = A
m−1, which is known by induction.
Thus
CAm−1 =
(
γV H
aV + γV H
, 0, 0, · · · , aV
aV + γV H
)
Qm−1m−1
=
(
1−
( aV
aV + γV H
)m
,
( aV
aV + γV H
)m
, 0, · · · , 0
)
(2.2.65)
Substitute equation (2.2.65) into equation (2.2.64), we getQmm equals what we have stated
in (2.2.61). Hence the system has a stationary state with the probability PH =
(
aV
aV +γV H
)m
of virus extinction and the probability PD = 1−
(
aV
aV +γV H
)m
of cell extinction.
Method 2: Direct solution of master equation for the reduced system
We have also found the analytical solution of the master equation for the reduced system.
As before, we start with examples in which the initial number of viruses is 1, 2, and 3.
Case 1: m = 1 The system (2.2.47) becomes:
dP2
dt
= γV HP1
dP0
dt
= aV P1 (2.2.66)
dP1
dt
= −(aV + γV H)P1
Let P = (P2, P0, P1)
T , then P (0) = (0, 0, 1)T . The eigenvalues of the coefficient matrix on
the right hand side of (2.2.66) are λ1 = 0, λ2 = 0 and λ3 = −(γV H + aV ). The associate
eigenvectors are v1 = (1, 0, 0)
T , v2 = (0, 1, 0)
T , and v3 =
(
−γV H
av+γV H
, −aV
av+γV H
, 1
)T
. So the
solution of (2.2.66) can be written as
P (t) = c1v1 + c2v2 + c3e
−(aV +γV H )tv3 (2.2.67)
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Apply the initial condition to solve c1, c2 and c3. We get
c1 =
γV H
aV + γV H
, c2 =
aV
aV + γV H
, c3 = 1 (2.2.68)
So the solution of (2.2.66) is
P2(t) =
γV H
aV + γV H
(
1− e−(aV +γV H )t)
P0(t) =
aV
aV + γV H
(
1− e−(aV +γV H )t) (2.2.69)
P1(t) = e
−(aV +γV H )t
As time t approaches infinity, we have
P limit2 = 1−
aV
aV + γV H
, P limit0 =
aV
aV + γV H
, P limit3 = 0 (2.2.70)
The above results agree with the results obtained using EMC. Since we have analytically
solved the system, we can calculate the conditional mean extinction time of virus. Let ∆P0
be the probability change of P0 in a small time interval, thus ∆P0 = (aV P1)∆t. P
limit
0 ,
the normalized factor, is the limiting probability that the system ends at healthy state, in
the other word, virus go extinction. So the conditional mean virus extinction time can be
calculated in the following way:
〈tV 〉 = 1
P limit0
∑
t(∆P0) =
(
aV
aV + γV H
)−1 ∫ ∞
0
t(aV P1)dt
= (aV + γV H)
∫ ∞
0
te−(aV +γV H)tdt (2.2.71)
=
1
aV + γV H
The variance of conditional virus extinction time is
varV = 〈t2V 〉 − 〈tV 〉2 =
1
(aV + γV H)2
(2.2.72)
Case 2: m = 2 The system (2.2.47) becomes:
dP3
dt
= γV HP1 + 2γV HP2
dP0
dt
= aV P1 (2.2.73)
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dP1
dt
= 2aV P2 − (aV + γV H)P1
dP2
dt
= −2(aV + γV H)P2
Let P = (P3, P0, P1, P2)
T , then P (0) = (0, 0, 0, 1)T . The eigenvalues of the coefficient
matrix on the right hand side of (2.2.73) are λ1 = 0, λ2 = 0 and λ3 = −(aV + γV H),
λ4 = −2(aV + γV H). The associate eigenvectors are v1 = (1, 0, 0, 0)T , v2 = (0, 1, 0, 0)T , and
v3 =
(
−γV H
aV +γV H
, −aV
av+γV H
, 1
)T
, v4 =
(
−γ2
V H
(aV +γV H)2
,
−a2
V
(av+γV H )2
, −2aV
aV +γV H
)T
. Similarly as we did in
(2.2.66), by applying the initial condition, (2.2.73) can be solved as
P3(t) = c1 + c3
−γV H
aV + γV H
e−(aV +γV H )t + c4
−γV H2
(aV + γV H)
2 e
−2(aV +γV H )t
P0(t) = c2 + c3
−aV
aV + γV H
e−(aV +γV H )t + c4
−aV 2
(aV + γV H)
2 e
−2(aV +γV H )t
P1(t) = c3e
−(aV +γV H )t + c4
−2aV
aV + γV H
e−2(aV +γV H )t (2.2.74)
P2(t) = c4e
−2(aV +γV H )t
where the values of the coefficients are
c1 = 1−
(
aV
aV + γV H
)2
, c2 =
(
aV
aV + γV H
)2
,
c3 =
2aV
aV + γV H
, c4 = 1 (2.2.75)
As time t approaches infinity, we have
P limit3 = c1 = 1−
(
aV
aV + γV H
)2
P limit0 = c2 =
(
aV
aV + γV H
)2
(2.2.76)
P limit1 = P
limit
2 = 0
Then the conditional virus extinction time is
〈tV 〉 =
∑
t(∆P0)/P
limit
0
=
(
aV
aV + γV H
)−2 ∫ ∞
0
t(aV P1)dt
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=(
aV + γV H
aV
)2 ∫ ∞
0
t
(
2aV
aV + γV H
e−(aV +γV H )t − 2aV
aV + γV H
e−2(aV +γV H )t
)
dt
=
3
2(aV + γV H)
(2.2.77)
The variance of conditional virus extinction time is
varV = 〈t2V 〉 − 〈tV 〉2 =
5
4(aV + γV H)2
(2.2.78)
Case 3: m = 3 The system (2.2.47) becomes:
dP4
dt
= γV HP1 + 2γV HP2 + 3γV HP3
dP0
dt
= aV P1
dP1
dt
= 2aV P2 − (aV + γV H)P1
dP2
dt
= 3aV P3 − 2(aV + γV H)P2 (2.2.79)
dP3
dt
= −3(aV + γV H)P3
The initial condition is P (0) = (0, 0, 0, 1)T . Similarly, we solve this system by finding its
eigenvalues and associated eigenvectors of the coefficient matrix. The solution is below:
P4(t) = 1− P0(t)− P1(t)− P2(t)− P3(t)
P0(t) =
a3V
(aV + γV H)3
(
1− e−(aV +γV H )t)3
P1(t) =
3a2V e
−(aV +γV H )t
(aV + γV H)2
(
1− e−(aV +γV H)t)2 (2.2.80)
P2(t) =
3aV e
−2(aV +γV H )t
aV + γV H
(
1− e−(aV +γV H )t)
P3(t) = e
−3(aV +γV H )t
As time t approaches infinity, we have
P limit4 = 1−
(
aV
aV + γV H
)3
, P limit0 =
(
aV
aV + γV H
)3
(2.2.81)
P limit1 = P
limit
2 = P
limit
3 = 0
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Then the conditional virus extinction time is
〈tV 〉 =
∑
t(∆P0)/P
limit
0 =
(
aV
aV + γV H
)−3 ∫ ∞
0
t(aV P1)dt =
11
6(aV + γV H)
(2.2.82)
The variance of conditional virus extinction time is
varV = 〈t2V 〉 − 〈tV 〉2 =
49
36(aV + γV H)2
(2.2.83)
After these examples, we are ready to formulate the general result:
General Case: The initial number of virus is m. Let P = (Pm+1, P0, P1, . . . , Pm)
T be
the probability of state m+ 1, 0, 1, ..., m.
Theorem 2.2.2. When the initial condition of the system (2.2.47) is P (0) = (0, 0, . . . , 0, 1)T
with size 1× (m+ 2), the solution of (2.2.47) is:
Pk(t) =
Ckma
m−k
V
(aV + γV H)m−k
e−k(aV +γV H )t(1− e−(aV +γV H )t)m−k, k = 0, 1, ..., m
Pm+1t = 1−
m∑
k=0
Pk(t) (2.2.84)
where Ckm =
m!
(m−k)!k!
. The conditional mean virus extinction time is given by
〈tV 〉 = 1
(aV + γV H)
∑m
i=1
1
i
(2.2.85)
and the variance of conditional virus extinction time is given by
varV =
1
(aV + γV H)2
∑m
i=1
1
i2
(2.2.86)
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Proof. The result can be proven by direct substitution. When k = 0,
P˙0(t) =
(
amV
(aV + γV H)m
(1− e−(aV +γV H )t)m
)′
=
amV
(aV + γV H)m−1
me−(aV +γV H)t(1− e(−aV +γV H )t)m−1
= aV P1(t) (2.2.87)
When k = 1, 2, ..., m− 1,
P˙k(t) =
(
Ckma
m−k
V
(aV + γV H)m−k
e−k(aV +γV H )t(1− e−(aV +γV H )t)m−k
)′
=
Ckma
m−k
V
(aV + γV H)m−k
(aV + γV H)e
−k(aV +γV H )t
(−k(1 − e−(aV +γV H )t)m−k)
+
Ckma
m−k
V
(aV + γV H)m−k
(aV + γV H)e
−k(aV +γV H )t(m− k)e−(aV +γV H )t(1− e−(aV +γV H )t)m−k−1
= −k(aV + γV H)Pk(t) + C
k
ma
m−k
V (m− k)
(aV + γV H)m−k−1
e−(k+1)(aV +γV H )t(1− e−(aV +γV H )t)m−k−1
= −k(aV + γV H)Pk(t) + (k + 1)aV Pk+1(t) (2.2.88)
When k = m,
P˙m(t) =
(
e−m(aV +γV H )t
)′
= −m(aV + γV H)Pm(t) (2.2.89)
Hence formulas in (2.2.84) give the solution of (2.2.47).
The conditional virus mean extinction time can be deduced as follows:
〈tV 〉 = 1
P limit0
∫ ∞
0
t(aV P1)dt
=
(
aV + γV H
aV
)m ∫ ∞
0
taV
mam−1V e
−(aV +γV H )t
(aV + γV H)m−1
(
1− e−(aV +γV H)t)m−1 dt
= m
∫ ∞
0
t(aV + γV H)e
−(aV +γV H)t
(
1− e−(aV +γV H )t)m−1 dt
= t
(
1− e−(aV +γV H )t)m ∣∣∣∞
t=0
−
∫ ∞
0
(
1− e−(aV +γV H )t)m dt
=
∫ ∞
0
dt−
∫ ∞
0
(
1− e−(aV +γV H)t)m dt
=
∫ ∞
0
dt−
∫ ∞
0
((
1− e−(aV +γV H )t)m−1 − (1− e−(aV +γV H )t)m−1 e−(aV +γV H )t) dt
=
∫ ∞
0
dt+
1
m(aV + γV H)
−
∫ ∞
0
(
1− e−(aV +γV H)t)m−1 dt
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...
=
1
(aV + γV H)
(
1
m
+
1
m− 1 + . . .+
1
2
)
+
∫ ∞
0
dt−
∫ ∞
0
(
1− e−(aV +γV H )t) dt
=
1
(aV + γV H)
(
1
m
+
1
m− 1 + . . .+
1
2
)
+
∫ ∞
0
e−(aV +γV H)tdt
=
1
(aV + γV H)
(
1
m
+
1
m− 1 + . . .+
1
2
+ 1
)
=
1
(aV + γV H)
∑m
i=1
1
i
(2.2.90)
The formula for the second moments of conditional virus extinction time is:
〈
t2V
〉
=
1
P limit0
∫ ∞
0
t2(aV P1)dt
=
(
aV + γV H
aV
)m ∫ ∞
0
t2aV
mam−1V e
−(aV +γV H )t
(aV + γV H)m−1
(
1− e−(aV +γV H )t)m−1 dt
= m
∫ ∞
0
t2(aV + γV H)e
−(aV +γV H )t
(
1− e−(aV +γV H)t)m−1 dt
= t2
(
1− e−(aV +γV H )t)m ∣∣∣∞
t=0
−
∫ ∞
0
2t
(
1− e−(aV +γV H )t)m dt
=
∫ ∞
0
2tdt−
∫ ∞
0
2t
(
1− e−(aV +γV H ))m−1 dt+ ∫ ∞
0
2te−(aV +γV H )t
(
1− e−(aV +γV H )t)m−1 dt
...
=
∫ ∞
0
2tdt−
∫ ∞
0
2t
(
1− e−(aV +γV H )t
∑m−1
i=0
(
1− e−(aV +γV H)t)i) dt
=
∑m−1
i=0
∫ ∞
0
2te−(aV +γV H )t
(
1− e−(aV +γV H )t)i dt
=
∑m
i=1
2
i(aV + γV H)
(∫ ∞
0
dt−
∫ ∞
0
(
1− e−(aV +γV H )t)i dt) by (2.2.85)
=
2
(aV + γV H)2
∑m
i=1
1
i
∑i
k=1
1
k
(2.2.91)
Thus the variance of the conditional virus extinction time is:
varV =
〈
t2V
〉− 〈tV 〉2
=
2
(aV + γV H)2
∑m
i=1
1
i
∑i
k=1
1
k
−
(
1
(aV + γV H)
∑m
i=1
1
i
)2
=
1
(aV + γV H)2
∑m
i=1
1
i2
(2.2.92)
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Recall that the Gillespie’s direct method computes the probabilities and conditional mean
time of extinction numerically when n is large. If we take V0 = 3, the trajectories using the
Gillespie algorithm reveal that the limits of virus and cell extinction probabilities are 0.36
and 0.64 and the limit of conditional mean virus extinction time is 0.76, see Figure 8. Let’s
substitute parameter values into the equation (2.2.84) and let t→∞. We obtain the mean
extinction probabilities of virus and cell:
P limit0 =
(
1.7
1.7 + 0.7
)3
= 0.36, P limit4 = 1− P limit0 = 0.64 (2.2.93)
We can also substitute the parameters in equation (2.2.85) of mean virus extinction time:
〈tV 〉 = 1
(1.7 + 0.7)
(
1
3
+
1
2
+ 1
)
= 0.76 (2.2.94)
We can see that all these values agree with the numerical results. In Figure 10 shows
the variance when V0 = 1. By applying formula (2.2.86), we have varV = 1/2.4
2 = 0.17, the
same as the variance in Gilliespie’s, while the variance in Laplace’s is a little smaller. This
verifies that Gillespie’s algorithm is more accurate than Laplace’s method when n is large
since (2.2.86) is based on the assumption that n is large.
Formula (2.2.85) and (2.2.86) of the mean and variance of virus extinction time in the ap-
proximate model are similar to the formulas in the standard birth-death model in Newman’s
paper [67].
2.2.2.5 Conclusion of the Stochastic Model In the ODE model, Figure 2 and 3
have showed that the system has three different parameter regions. The stable healthy
state (V,H, I) = (0, 1, 0) becomes unstable and an additional steady state - chronic state,
appears at n ≈ 5. Then the steady chronic state becomes unstable and the a limit cycle
appears through a Hopf bifurcation at n ≈ 23. The stochastic model also has 3 parameter
regions. When n < 6, the virus has an extinction probability 1. That probability decreases
monotonically when 6 ≤ n < 25, and then it reaches a limiting value at n ≈ 25.
We have explored three methods of analysis of the stochastic model: by simulation of the
trajectories by the algorithm of Gillespie’s direct method, by solving mean extinction times
through Laplace transform of the master equation, and by generating formulas for limiting
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probability of healthy and dead states and the moments of virus extinction time using a
reduced Markov chain.
Gillespie’s direct method is capable of dealing with large systems as the required com-
puter memory depends linearly on number of species. Its disadvantage is that many tra-
jectories do not converge to absorbing states and long time simulations are needed for an
accurate estimation of extinction times. The Laplace method is fast and accurate. But it
can be used only when the system size is small. It requires more memory than Gillespie
algorithm when dealing with the same system. The size of the truncated master equation
suffers from an exponential growth for an increasing number of chemical species. Elf [26]
states that when number of reactions is large, there is no other alternative than a Monte
Carlo method.
Other method in the field of stochastic modeling utilizes approximation of the master
equations by a continuous Fokker-Planck equation (FPE), which is a partial differential equa-
tion in time and N-dimensional space. FPE is well suited for problems in low dimensions
especially if high accuracy is desirable. But it is only applicable to problem with few molec-
ular species. Sjoberg [77] states that FPE is less accurate than Gillespie’s direct method
when the species number is greater than 2. Doering [21] found FPE approximation is valid
only near the threshold. Other approximation methods, i.e. chemical Langevin equation,
are discussed by Gillespie [33].
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2.3 HUMAN IMMUNE RESPONSE
The analysis of the basic system in the previous section shows that in the absence of
any immune response, an infected organism is able to recover only for extremely inefficient
viruses. The two other possible outcomes are rapid convergent to a dead state and a persis-
tent infection for weak viruses that will approach the dead state eventually. In this section,
we show that the immune response makes the disease manageable by:
• isolating the system trajectories from the states that lead to the absorbtion in the dead
state
• lowering the total damage to the system,
• shortening the duration of infection (i.e., shortening the mean time of virus extinction),
• increasing the virus extinction probability.
As we mentioned earlier, the immune response to influenza virus has three components:
innate, cellular, and adaptive [3, 42]. The innate immune component is localized in the
place of infection and is primarily mediated by macrophages and infected cells producing
interferons which make susceptible cells resistant to infection. In cellular immune component,
signals about the presence of the virus are carried to lymph nodes by antigen presenting cells.
Effectors cells pick up on that signal, mature, and migrate to the site of infection, where
they neutralize infected cells. In the adaptive immune component, antigens are carried to
bone marrow where they are recognized by B-cells. These mature into plasma cells which
produce antibody specific to the antigen. The antibodies help to neutralize virus and offer
protection from future infection by this same virus. We shall explore the role of each negative
feedback separately and in combination with the others mathematically. Figure 16 shows
mean extinction times and probabilities in the basic system by the algorithm of Gillespie’s
direct method. Because the system’s behavior changes qualitatively between n = 6 and 8,
we call n∗ = 6 a bifurcation of the system. For n ≤ n∗ the virus extinction probability is 1
and the cell extinction probability is 0, i.e., virus extinction is assured.
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Figure 16: Conditional mean times and probabilities of extinctions in the basic system,
H∗ = 100, V0 = 3. All the trajectories are averaged over 50,000 independent samples
generated by Gillespie algorithm. The x-axis is n = γV /aI and it is in log scale.
2.3.1 Systems with an Innate Immune Component
The term innate immune component describes a nonspecific response of the organism to a
viral infection that is generally mediated by α and β interferon molecules produced by antigen
presenting cells which detect the presence of the virus in the system. Interferons interact with
the healthy cells and convert them into a resistant state, thereby preventing the virus from
spreading efficiently. Mathematically, the innate immune component provides a negative
feedback that lowers the virus level. To model the innate response discussed in Hancioglu’s
paper [40], we assumed the presence of three additional components to the system: the
activated antigen presenting cells (M) , the interferon (I), and the resistant cells (R). (Here
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we modify the model in Hancioglu’s paper [40] by assuming that the interferon molecules are
generated solely by infected cells, without any contribution from antigen presenting cells.)
The scheme of the corresponding modified system is:
Resistant
R
Interferon
F
H lthea y
H
IAV
V
Infected
I
Dead
D
Figure 17: Systems with an innate immune component
The reaction network of the innate immune component is:
V +H
γV H−−→ I
I
aI−→ nV +D
V
aV−→ ∅
H +D
bHD−−→ 2H
I
bF−→ I + F (2.3.1)
H + F
bFH−−→ R (2.3.2)
F
aF−→ ∅ (2.3.3)
R
aR−→ H (2.3.4)
The presence of resistant cells gives rise to new terms in the equation for healthy cells
corresponding to the reproduction of resistant cells, loss of resistance, and conversion of
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healthy cells into resistant ones. Antigen presenting cells are simulated by the damage (i.e.,
dead remnants of infected cells, D = 1 − I − R − H), and produce interferon. Interferon
molecules interact with healthy cells and convert them into a resistant state. Resistant cells
naturally loose resistance and also can reproduce to give rise to healthy cells.
The analysis of influenza A infection in humans [40] yielded the following estimates for
the additional parameters. F is re-scaled by 1700 and some other parameters are adjusted
by the homeostatic level in our Gillespie algorithm: bF = 125, bFH = 17/H
∗, aF = 8,
aR = 1. The healthy absorbing state of the system is (V,H, I, R, F ) = (0, H
∗, 0, 0, 0) and
dead absorbing state is (V,H, I, R, F ) = (0, 0, 0, 0, 0).
Recall in the basic ODE system, there is a limit cycle as γV increases. The presence
of the innate immune component preserves the structure of the basic diagram (i.e. healthy
state stable for small γV , then branching into a chronic state) with the exception of missing
limit cycle. This implies that innate immune component stabilizes the chronic state for large
values of γV . (Marissa Goldrich and David Swigon, unpublished result.)
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Figure 18: Conditional mean times and probabilities of extinctions in the system with innate
immune component. H∗ = 100, V0 = 3 and all the trajectories are averaged over 50,000
independent samples generated by Gillespie algorithm. The x-axis is n = γV /aI . The blue,
green, and pink trajectories represent the maximum simulation time Tmax = 20, 40 and 60,
correspondingly.
Figure 18 is generated by the Gillespie algorithm with H∗ = 100 and V0 = 3 (Laplace
transform method is not applicable to the analysis of the system due to its size.) Compared
with the basic system, the innate immune component results in a large increase in n∗. The
bifurcation occurs at n∗ = 120 with the innate immune component included. In basic
system, the virus extinction probability reaches the limiting probability when n > 25 while
with the innate immune component, it doesn’t reach the limit until n > 103. In the plots of
conditional mean virus extinction time and probability, we notice that both curves rebound
when n > 200. This is because what we calculate is the conditional mean extinction time.
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When 10 < n < 200, a large part of the simulated trajectories are of type III (no-extinction
category), corresponding to a chronic infection. Those type III trajectories lead to an under-
estimation of the conditional mean extinction time. If we run the simulation long enough,
we expect these type III trajectories to end in either virus extinction or cell extinction. We
have run the trajectories with the maximum simulation time Tmax = 20, 40, and 60. Figure
18 shows that the longer maximum simulation time results a higher peak of the conditional
mean extinction time. Ideally, the curve of virus extinction probability should decrease
monotonically until it reaches the limiting probability. When n is between 20 to 120, the
two flat lines in virus extinction time and probability are equal to the limiting extinction time
tV = 0.76 and probability PV = 0.36, respectively. The reduced Markov chain in limiting
case of innate component is the same as that of the basic system. The limiting extinction
probabilities here are also: 0.64 for cell extinction and 0.36 for the virus extinction.
2.3.2 Systems with a Cellular Immune Component
The cellular immune component refers to the mechanism of a specific response in which
infected cells are neutralized by the action of effector cells (usually CTL’s or natural killer
cells). This mechanism reduces the source of new virus particles and hence constitutes
another form of a negative feedback. The additional components of the system are antigen
presenting cells (M) and effector cells (E). The scheme of this system is:
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Figure 19: Systems with a cellular immune component
The reaction network of the cellular immune component is:
V +H
γV H−−→ I
I
aI−→ nV +D
V
aV−→ ∅
H +D
bHD−−→ 2H
D +N
bMD−−→ D +M (2.3.5)
M
aM−−→ N (2.3.6)
M
bEM−−→ M + E (2.3.7)
E + I
bEI−−→ D (2.3.8)
∅
bE−→ E (2.3.9)
E
aE−→ ∅ (2.3.10)
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Antigen presenting cells are stimulated by the damage (i.e., dead remnants of infected
cells, here D = 1−I−H ), the production of effector cells is controlled by the APCs and the
effector cells interact with the infected cells and neutralize them, with p = (bIEH
∗)/(bEIE
∗)
the average amount of infected cells destroyed by one effector cell. Reaction (2.3.9) and
(2.3.10) correspond to a homeostatic maintenance effect by which the organism strives to
maintain the population of effector cells at a homeostatic level. Effector cell E is re-scaled as
the multiple of the homeostatic level E∗ = 6× 107. The analysis of influenza A infection in
Hancioglu’s paper [40] yielded the following estimates for the additional parameters (some
of the parameters are adjusted by the homeostatic level in our Gillespie algorithm): bMD =
2/H∗, aM = 0.5, bEM = 8.3E
∗/M∗, bEI = 4.72/H
∗, bE = 0.4H
∗, 0.4. The healthy state
of the system is (V,H, I,N,M,E) = (0, H∗, 0,M∗, 0, E∗) and dead absorbing states are
(V,H, I,N,M,E) = (0, 0, 0, ND,MD,ED).
Figure 20 is generated by the Gillespie algorithm with H∗ = 100, M∗ = 20, E∗ = 10
and V0 = 3. The system with cellular immune component has the bifurcation at n
∗ = 10
while the basic system has n∗ = 6. The virus extinction time reaches the limit when n = 50
in this system compared with n = 12 in basic system. It seems cellular immune component
doesn’t have much improvement at these two n values compared with the innate immune
component. Its most important advantage is that the limiting probability of virus extinction
is increased from 0.36 to 0.47, and correspondingly, the limiting probability of cell extinction
is decreased from 0.64 to 0.53.
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Figure 20: Conditional mean times and probabilities of extinctions in the system with cellular
immune component. H∗ = 100, M∗ = 2, E∗ = 10, V0 = 3, and all the trajectories are
averaged over 50,000 independent samples generated by Gillespie algorithm. The x-axis is
n = γV /aI .
We have constructed an approximate Markov Chain to derive the limiting probability of
this system - with cellular immune component.
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Figure 21: Schema of the approximate Markov chain in the system with a cellular immune
component, b′EI = bEI/E
∗.
Figure 21 is the simplified Markov chain of the system with a cellular immune component.
Recall in the approximate model of the basic system, if n is large, once the reaction V +
H
γV H−−→ I occurs, then the system enters the dead absorbing region. We shall use the same
approximation here. The difference is that in the system with cellular immune component,
the infected cell can be cleared by E+I
bEI−−→ D. So there is two ways to approach the healthy
state - from state (V, I) = (1, 0) and state (V, I) = (0, 1). Enumerate all the states in the
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Figure 21 and find the limit of the transition matrix. The limiting probability of absorbing
states are solved through the embedded method [78], which we have discussed in the basic
system.
Theorem 2.3.1. In the system with a cellular immune component, when n → ∞, the
limiting probability PH of the healthy state and the limiting probability PD of the dead state
are
PH =
(
aIaV + b
′
EI(aV + γV H)
aI(aV + γV H) + b′EI(aV + γV H)
)V0
(2.3.11)
PD = 1− PH (2.3.12)
where b′EI = bEI/E
∗.
Proof. This can be proved using the embedded Marko Chain method [78], similarly as we
did in Theorem 2.2.1.
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2.3.3 Systems with Combined Innate and Cellular Immune Components
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Figure 22: Systems with combined innate and cellular immune Components
The combination of innate and cellular immune components leads to postponement of the
bifurcation to larger value of n and an increase in the virus extinction probability (see Figure
23). The bifurcation occurs at n∗ = 200. The rebound in the virus extinction probability
remains because of the limited simulation time. If we run the simulation long enough, the
chronic states will terminate primarily in the dead state. The curve of the virus extinction
probability should decrease smoothly to the limiting probability. The system has a healthy
state at (V,H, I, R, F,N,M,E) = (0, H∗, 0, 0, 0,M∗, 0, E∗) and dead absorbing states that
satisfy (V,H, I, R, F,N,M,E) = (0, 0, 0, 0, 0, ND,MD,ED). The reduced Markov chain in
limiting case here is the same as the one in the system with only cellular immune response
with limiting probabilities of cell extinction PC = 0.53 and virus extinction PV = 0.47.
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Figure 23: Conditional mean times and probabilities of extinction in system with combined
innate and cellular immune components. H∗ = 100, M∗ = 20,E∗ = 10,V0 = 3 and all the
trajectories are averaged over 50,000 independent samples generated by Gillespie algorithm.
The x-axis is n = γV /aI .
2.3.4 Systems with a Complete Immune Response
In this section, we consider the combination of all the three immune components. The
effect of adaptive immune component on the stability of the healthy state in the ODE model
was discussed at length in Hancioglu’s paper [40]. For completeness, adaptive immune
component helps in clearing the infection by producing antibodies that neutralize the virus
particles by rendering them unable to infect healthy cells. The antibodies are produced by
plasma cells, production of which is stimulated by APCs. The new components of the system
are plasma cells (P) and antibodies (A).
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Figure 24: Human immunity system - combined innate, cellular and adaptive immune com-
ponents
The new reactions added here are:
M
bPM−−→ M + P (2.3.13)
∅
a′P−→ P (2.3.14)
P
aP−→ ∅ (2.3.15)
P
bPA−−→ P + A (2.3.16)
V + A
γAV−−→ ∅ (2.3.17)
A
aA−→ ∅ (2.3.18)
The production of plasma cells is stimulated by activated macrophages and the produc-
tion of antibodies is stimulated by plasma cells. Antibodies remove viruses and have natural
decays. The parameter corresponded to antigenic compatibility of antigenic compatibility
of antibodies is assumed to be constant. The parameter values are again estimated from
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Hancioglu’s paper [40]. We have adjusted some values by the homeostatic level in our Gille-
spie algorithm: bPM = 11.5P
∗/M∗, a′P = 0.4P
∗, aP = 0.4, bPA = 0.043A
∗/P ∗, γV A =
14.6/H∗, aA = 0.043. The system has a healthy state at (V,H, I, R, F,N,M,E, P, A) =
(0, H∗, 0, 0, 0,M∗, 0, E∗, P ∗, A∗) and dead absorbing states (V,H, I, R, F,N,M,E, P, A) =
(0, 0, 0, 0, 0, ND,MD,ED, PD,AD).
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Figure 25: Conditional mean times and probabilities of extinction in human immunity.
H∗ = 100, M∗ = 20, E∗ = 10, P ∗ = 10, A∗ = 100, V0 = 3, and all the trajectories are
averaged over 50,000 independent samples generated by Gillespie algorithm. The x-axis is
n = γV /aI . The trajectories of the system with no immune component, with innate immune
component, with cellular immune component, with the combination of innate and cellular
immune components, and with the complete immune response - the combination of innate,
cellular and adaptive immune components are in blue, green, red, pink, and black. The
purple arrow represents biologically reasonable values of n.
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Figure 25 summarizes the earlier graphs and adds the plots for the combined response.
The bifurcation occurs at n∗ ≈ 300 for the black curve. The purple arrow at the bottom of
each plot represents biologically reasonable reproduction numbers for viruses. All three types
of immune components are essential. In the basic system (blue lines in Figure 25), healthy
cells go extinct at small number of n and the organism dies. The innate (green) immune com-
ponent substantially reduces cell extinction probability when n < 200 and promotes chronic
disease. The cellular (red) immune component increases the virus extinction probability at
any n numbers. Then the combination of two (pink) almost eliminate cell extinction and
significantly increase virus extinction rate. The adaptive immune component aids in virus
clearance and prevents infection altogether. The conditional mean virus extinction time is
shortened substantially. The probability of virus extinction is above 90% across the range
of n. The probability of cell extinction is nonzero only for n above 103. The combination
of the three immune component (black) makes the human body almost invulnerable under
virus attack unless a large number of viruses can be generated from a single infected cell.
Theorem 2.3.2. In the system with innate, cellular and adaptive immune components, when
n → ∞, the limiting probability PH of the healthy state and the limiting probability PD of
the dead state are
PH =
(
(aV + γAVA
∗)aI + (aV + γAVA
∗ + γV H)b
′
EI
(aV + γAVA∗ + γV H)(aI + b′EI)
)V0
(2.3.19)
PD = 1− PH (2.3.20)
where b′EI = bEI/E
∗.
Proof. This can be proved through the embedded method [78], which we have discussed in
the basic system.
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3.0 VOCAL FOLD INFLAMMATION
3.1 INTRODUCTION
Human vocal folds are located in the larynx. When air stream from the lungs passes
through the vocal folds, they will be set into oscillation and produce a periodic train of air
pulses. That is how sound is produced. If the vocal folds are stressed or traumatized by
noxious stimuli, the tissue properties of the vocal folds will be altered and the vocal fold
oscillation will be disturbed, result in an altered voice quality, i.e., a voice disorder [51].
Phonotrauma
Voice disorders appear to be the most common communication disorders across the hu-
man lifespan [74]. In most cases, these disorders are not ”cosmetic”. They can produce
substantial negative effects on quality of life in affected individuals as well as substantial
negative economic impact on society [86]. A common cause of voice disorder is phono-
trauma, which is a vocal fold injury associated with phonation (i.e., voice production).
When people speak or sing, the vocal folds oscillate at a relatively high frequency. Typi-
cally, the vocal folds make contact at some point during the vibratory cycle. The associated
motions generate various types of bio-mechanical forces within the oscillating vocal fold tis-
sues [37, 38, 43, 80]. Although micro-injury likely occurs within the tissue every day, injury
may or may not be functionally relevant, depending on the magnitude of the injury and the
host’s requirement for an intact voice. Specifically, under conditions of typical voice use,
the tissues are generally competent to withstand the bio-mechanical forces physiologically,
probably with relatively minor and transient local inflammatory responses. In such cases,
the levels of tissue injury are sufficiently microscopic to be regenerated intrinsically without
a full scale inflammatory or wound healing response. On the other hand, when phonation
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conditions are frankly phonotraumatic, the associated bio-mechanical forces are sufficiently
large to cause substantial cell death and macroscopic tissue damage. If such conditions per-
sist without adequate rest, damaged tissue does not have time needed to repair [81]. As a
result, benign lesions at the mid-membranous vocal folds may develop, leading to dysphonia
and voice-related changes in quality of life [58].
Therapeutic management of phonotrauma may involve medical or sometimes surgical
intervention. However, behavioral voice therapy is generally considered central to any treat-
ment program, and is usually preferred as the first-line approach [6, 14, 44]. Unfortunately,
strong scientific evidence is still lacking regarding the effectiveness and efficacy of voice ther-
apy for phonotrauma. One of the research obstacles is that the underlying mechanism of
inflammation and healing underlying phonotrauma is highly complex. Common research
approaches, such as randomized clinical trials, are not sufficient to capture the dynamics of
the disease and its response to treatments [51]. In this study, a systems biology approach
utilizing computational modeling was used to simulate acute phonotrauma and its response
to behavioral treatments.
Development of mathematical models of inflammation and healing
Inflammation and healing, which are innate tissue responses to mechanical stress/ trauma,
are regulated by a complex dynamic system. A modeling approach, which combines empiri-
cal, mathematical and computational tools, was taken to study the biological complexity of
this dynamic system.
Computational agent-based models (ABMs) were developed to quantitatively character-
ize multiple cellular and molecular interactions around inflammation and healing. Initially,
the ABMs of the vocal fold injury were specified to the setting of phonotrauma, a bio-
mechanical injury owing to phonation. These models allowed for tests of various hypotheti-
cal effects of motion-based treatments in individuals with acute phonotrauma [53, 51]. The
phonotrauma ABMs were calibrated and validated with empirical data of a panel of inflam-
matory mediators, obtained from laryngeal secretions in individuals following experimentally
induced phonotrauma and a randomly assigned motion-based treatment. In addition, an
ABM of surgically induced vocal fold trauma was developed and subsequently calibrated to
empirical data of inflammatory mediators and extracellular matrix substances from rat stud-
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ies [51]. In general, ABM simulations reproduced and predicted trajectories of inflammatory
mediators and extracellular matrix as seen in empirical data of phonotrauma and surgical
vocal fold trauma. The simulation results illustrated a spectrum of inflammatory responses
to phonotrauma, surgical trauma and motion-based treatments.
In addition to the use of ABMs for simulating vocal fold injuries [53, 51], the parallel
development of an ordinary differential equation (ODE) model for phonotrauma was pur-
sued in the interest of cross-platform comparison of results [52]. A rudimentary ODE was
developed using the module of system dynamics included in the Netlogo platform (Center
for Connected Learning and Computer-Based Modeling, Northwestern University, Evanston,
IL). To test the validity of our agent-based model of phonotrauma, ”model docking” was
used. ”Model docking” is a well-vetted validation strategy based on a comparison of pre-
dictions from different models across an array of user input data. The finding of similar
predictions in agent-based and equation-based models would increase confidence in the un-
derlying assumptions made in the previous ABM. In this comparison study, the ABM and
ODE model predicted similar cellular and molecular patterns for inflammatory and wound
healing responses under small initial damage. However, the models’ results diverged in their
predictions of inflammatory and wound healing responses for a large initial insult. The other
limitation was that the module of system dynamics in Netlogo was just released at the time
of the project. The module was limited for conventional mathematical analysis, such as,
parameter fitting and sensitivity tests.
Therefore, in the current study, we adopted the well-established MATLAB platform to
rigorously pursue the development of ODE models in simulating inflammation and healing in
the setting of vocal folds. Acute inflammation has been simulated by equation-based model-
ing [12, 18, 48, 76]. Kumar et al. [48] reported a three-variable ordinary differential equation
model of acute inflammation. The model consists of a pathogen and two inflammatory me-
diators. In the model, an infectious agent triggered an early inflammatory mediator to kill
the pathogen and later another inflammatory mediator was triggered to further exacerbate
inflammation. The model was able to reproduce the health state and various negative states
as observed in severely infected patients. Their simulation results also point out that the
clinical presentations of severe infection arise from diverse underlying physiological states
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and thus different therapeutic approaches are required.
Later, a study Reynolds et al. [76] reported a four-variable model of acute inflamma-
tion. This model is expanded from Kumar et al.’s [48] model by incorporating an anti-
inflammatory mediator in the system. The anti-inflammatory mediator in the model has
the functions of (1) inhibiting the build-up of pro-inflammatory mediator and the tissue
damage, and (2) promoting further production of anti-inflammatory mediator. Their simu-
lation results suggest that the rates of dynamic anti-inflammatory response may be modified
therapeutically to yield optimal healing outcome after pathogenic infection.
Day et al. [18] used the same four-variable model of acute inflammatory response to
explore the effects of repeated administration of endotoxin (bacterial lipopolysaccharide) on
the system. Their model was capable to display the clinical scenarios of endotoxin tolerance
and potentiation from a single parameter set with repeated endotoxin challenges. This
finding suggests that various biological responses (endotoxin tolerance and potentiation)
to repeated bacterial infection are dynamic manifestations of a unified acute inflammatory
response.
Along the line of this research, a study reported the work of calibrating an acute inflam-
matory model to experimental data in mice with endotoxemia, surgical trauma or surgical
trauma followed by hemorrhage [12]. The model was capable to predict a dose range of
endotoxin leading to death of mice, despite being calibrated on data from non-lethal inflam-
matory insults. The most current model was calibrated to simulate acute inflammation in
mice, swine and human in order to scale up the model to the whole-patient level [88].
Lastly, an equation-based model was developed to demonstrate the application of inflam-
mation modeling for in silico clinical trial [13]. The model was set up to create a population
of 1,000 synthetic ”patients” with different clinical profiles. Then, these ”patients” were sub-
mitted to one of three types of anti-sepsis therapy (anti-tumor necrosis factor neutralizing
antibodies). Their simulation results suggest that anti-tumor necrosis factor therapy can be
both effective and harmful to the patients, depending on the dose and duration of treatment
as well as the patient’s clinical profiles.
That said these models focused on the inflammation ensued from either bacterial infec-
tion or surgical trauma. In this study, we developed a new inflammation and healing model
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to simulate early acute inflammatory responses (up to 24 hrs post phonotrauma) with input
variables describing the vocal loading conditions and develop tools that will allow this model
to effectively assimilate experimental data. We fitted the model against available experi-
mental data and conducted parameter sensitivity analysis. We investigated the parameter
space through metropolis sampling and parallel sampling method. Our goal is to develop a
method for proposing a patient specific vocal exercise and rest schedule that optimizes tissue
healing in cases of both acute and chronic phonotrauma.
3.2 EXPERIMENT, DATA AND ODE MODEL DEVELOPMENT
3.2.1 Experiment and Treatments
Data from 9 patients, six females (21-46 years old) and three males (21-49 years old),
were collected in a study involving one hour loud phonation followed by a 4-hour treatment
of three types: voice rest, spontaneous speech and resonant voice (roughly, classical singing)
[53, 51]. One female subject received all three treatments, randomly ordered without re-
placement on different days by separated intervals ranging from 1-6 months. All the other 8
subjects participated in only one treatment. After the treatment at clinic, all subjects were
discharged to home with instructions to continue their corresponding treatment in somewhat
less intense cycles for resonant voice and spontaneous speech conditions. Laryngeal secre-
tions are collected at 4 different times: at baseline, immediately after vocal loading, after
the 4-hour clinic treatment and 24 hours post-baseline.
The detail time schedule of the whole experiment is shown in Figure 26. Patients arrived
the clinic in the morning, and started laryngeal secretion baseline collection. Patients took
1 hour rest and then started the vocal loading, which has three consecutive cycles, each
involving 15 minutes of loud phonation followed by 5 minutes of silence, for a total of 60
minutes. We assign the time when patients started vocal loading as time t = 0. Right after
the vocal folding, time t = 1, laryngeal secretions are collected again and patients took 1
hour rest. Then the patients are randomly assigned to one of the three treatments: voice
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rest, spontaneous speech or resonant voice. At time t = 2.5, each subject started their own
treatment for 4 hours at the clinic. After the 4-hour treatment, laryngeal secretions were
collected and patients took a rest. Then they went home at t = 7.75. At 10 < t < 14,
patients were instructed to continue their corresponding treatment at home and then went
to bed after the treatment. They came back to the clinic next morning at t = 22.
t= 2,!patients!come!to!the!clinic;!start!to!baseline!collection
t=0,!finish!baseline!collection;!start!1!hr!loud!phonation
t=1,!stop!scream;!collect!secretion;!rest!!
t=2.5,!start!the!randomly!assigned!treatment
t=6.5,!finish!the!treatment;!collect!secretion;!rest
t=7.75,!patient!are!discharged!home
t=10,!begin!home!treatment
t=14 finish home treatment; go to sleep,! ! ! ! ! ! !
t=22,!come!back!to!the!clinic;!collect!the!secretion
Figure 26: Treatment and data collection schedule. Loud phonation is performed during
0 < t < 1, clinic treatment is during 2.5 < t < 6.5, and home treatment is during 10 < t < 14.
Laryngeal secretion is collected at t = 0, 1, 6.5, 22.
The three treatment modalities can be considered on a continuum of tissue mobilization
magnitude and intra-vocal fold impact stress magnitude. Voice rest has no mobilization
or impact stress, spontaneous speech has normal to large magnitude mobilization but po-
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tentially greater impact stress [73, 84], and resonant voice has normal to large magnitude
but relatively low impact stress [73, 84]. It is believed that resonant voice treatment might
result in a mostly anti-inflammatory response and therefore favors recovery from intense
pro-inflammatory stimuli.
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Figure 27: Vibration and impact stress loading values for the three treatments.
3.2.2 Data and ODE Model Development
Three subjects’ data is excluded because of their thick secretions that are too viscous
to pipette. One subject took all three treatments, thus we have nine valid treatment data
trails. The spontaneous speech group has two subjects, the voice rest group has three, and
the resonant voice has the left three. Figure 29 shows the average data of each treatment
before exclusion of outliers. The first two collections are averaged over all valid data trails
because the subjects are subject to the same conditions before they received their personal
treatment. We have the measurements of TNF, IL-1β, IL-6, and IL-10.
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Figure 28: Average data of TNF, IL-1β, IL-6, and IL-10 in three treatment groups. The first
two points are averaged over all the valid data set. The bars are the standard deviations.
In the early stage of the research, we developed the following model:
Σ =
D + αMIL1IL1
1 + αM(D + αMIL1IL1)
(3.2.1)
dD
dt
= M + αDI1I + αDI2DI − µDD (3.2.2)
dM
dt
= Σ−
(
1 +
αMTGF1TGF
1 + αMTGF2TGF
)(
IL10
1 + αMIL10IL10
)
µMM (3.2.3)
dIL1
dt
=
αIL1MM(1 + αIL1sΣ)
1 + αIL1IL10IL10
− µIL1IL1 (3.2.4)
dIL6
dt
=
αIL6MM
(1 + αIL6IL10IL10)
+
(
aIL6FF +
αIL6F1V F
1 + αIL6F2V
)
(
1 +
αIL6IL11IL1
1 + αIL6IL12IL1
)
− µIL6IL6 (3.2.5)
dIL10
dt
=
αIL10MM (1 + αIL10V V )
1 + αIL10IL10IL10
− µIL10IL10 (3.2.6)
dTGF
dt
= αTGFMM +
αTGFFF
1 + αTGFIL1IL1
− µTGFTGF (3.2.7)
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dF
dt
= αF
(
1 +
αFIL11IL1
1 + αFIL12IL1
)(
1 +
αFTGF1TGF
1 + αFTGF2TGF
)
− µFF (3.2.8)
dC
dt
= αCFF
(
1 +
αCTGF1TGF
1 + αCTGF2TGF
)
− µCC (3.2.9)
The model contains accounts for inflammation and healing processes. Two variables in
the model describe the input vocal loading conditions: impact stress (I) and vibratory stress
(V). The impact stress describes the magnitude of impact force exerted by one vocal fold
on the other during strong phonation and is the primary source of damage in the system.
[85]. The vibratory stress is generated by the vibration of vocal fold at any intensity and it
simulates the production of cytokines by macrophages in the vocal fold [49]. Vibratory stress
(V) and impact stress (I) are time-dependent variables according to the treatment schedule.
The variable (D) represents damaged or dead cells. Macrophages (M) destroy the healthy
cells and dominate in the early stage of inflammation. IL-1β (IL1) is pro-inflammatory
cytokine [20] that is produced by the macrophages [19, 20] and is the most important cytokine
for macrophage activation [59]. In the model, the damage and IL-1β form a pro-inflammatory
signal Σ, which stimulates macrophage activation. IL-1β is inhibited by anti-inflammatory
cytokine IL-10 (IL10) [59, 4, 79]. IL-6 (IL6) is another inflammatory mediator that is
produced by macrophages [56] and fibroblasts in response to IL-1β [22]. and is inhibited by
IL-10 [59, 79]. IL-10 is the main anti-inflammatory cytokine [1], which is also produced by
macrophages [11], and inhibits its own production to a lesser degree than it inhibits other
processes [17, 63]. TGF-β (TGF) is also an anti-inflammatory cytokine [1, 45], that is
produced by macrophages and fibroblasts [45]. Exposure of vocal fold fibroblasts to IL-1β
down-regulates TGF-β [54]. IL-10 and TGF-β deactivate macrophages [4, 5, 59]. Fibroblasts
(F) are important sources of anti-inflammatories and their proliferation is stimulated by IL-
1β and TGF-β [2, 23, 45]. Fibroblast population increases more than 1/3 under the influence
of TGF-β [57]. Collagen (C) plays critical role in tissue development and repair [70] and it
is mainly produced by fibroblast and TGF-β [7, 23, 55, 57].
The model (3.2.1)-(3.2.9) contains 8 variables and 40 parameters. Ideally, we would like
to estimate the parameters and expect the model effectively assimilate all the experimental
data. The difficulty here is that we only have valid data of IL-1β, IL-6 and IL-10 at 4 time
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points. In view of the limited available data, our model has too many degrees of freedom to
be fitted.
In order to avoid overfitting, we reduced our model to a four-variable model. Since
variables IL6, TGF, F and C are essentially decoupled from the others and not supported
by data, we eliminate them from the model. The reduced ODE model is shown here
Σ =
αM1(D + αMIL1IL1)
1 + αM2(D + αMIL1IL1)
(3.2.10)
dD
dt
= αDMM + αDI1I + αDI2DI − µDD (3.2.11)
dM
dt
= Σ− IL10
1 + αMIL10IL10
µMM (3.2.12)
dIL1
dt
=
αIL1MM(1 + αIL1sΣ)(1 + αIL1V V )
1 + αIL1IL10IL10
− µIL1IL1 (3.2.13)
dIL10
dt
=
αIL10MM(1 + αIL10V V )
1 + αIL10IL10IL10
− µIL10IL10 (3.2.14)
The reduced model was capable of explaining the data within the standard deviation.
We have explored the whole parameter space using the parallel sampling method, finished
the sensitivity analysis and parameter reduction, and fitted the reduced parameter set to
the data from individual patients. Although results were numerically acceptable, we were
concerned with the extensive variability observed between individuals. Should we just simply
take average data (naive pooling) of them and fit them despite the huge standard deviations?
For example, the peak of IL-10 in resonant voice group is pushed by a singe point, which is
out the plot because of its large value (> 2400). We also observed that some of the patients
have a high baseline and should be considered as pre-inflamed. It did not appear suitable to
take average over these pre-inflamed patients together with others.
To address these concerns, we went back and carefully reviewed the experimental data.
Each secretion collection of a single patient is measured twice. The primary measurements
show that two patients in the voice rest group have a high initial value of IL-1β, between
500 ng/ml to 1100 ng/ml. These two should be separated as an additional group called voice
rest pre-inflamed group. Thus, we have three subjects in the spontaneous speech group, two
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in the voice rest group, two in the voice rest pre-inflamed group and three in the resonant
group. All the primary collection measures are depicted in Figure 29.
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Figure 29: Valid primary collection measurements. n is the number of subjects in each group.
Four time points - baseline, after 1 hour screaming, after 4 hour clinic treatment and 22 hours
post screaming. The lines and bars represent the average and standard deviation of each
group. The highest point of IL-1β in spontaneous group is overlapped by two measurements
and so does that in resonant voice group. The lines are the average curves and bars are
standard deviations.
In Figure 29, every dot represents the measurement of each subject’s primary collection
at 4 time points. The highest point of IL-1β in the spontaneous group is overlapped by
two measurements and as is the case in the resonant voice group. In the spontaneous
speech treatment group, one IL-10 point (> 1200) is significantly higher than the other
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measurements (< 400) at the same time point. So we treated this measurement as an
outlier. IL-10 data in the voice rest pre-inflamed group has an outlier with value greater
than 1000 while all the other data at that time is below 200. In the data of IL-10 in the
resonant group, there is one point at t = 6.5 that not visible in the plot because it is greater
than 5,000 and one of its baseline is greater than 1000 while all the others are below 350.
These two measurements should also be treated as outliers.
Figure 30 plots all the primary measurements without outliers.
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Figure 30: Valid primary collection measurements with outliers eliminated. n is the number
of subjects in each group. Four time points - baseline, after 1 hour screaming, after 4 hour
clinic treatment and 22 hours post screaming. The lines and bars represent the average and
standard derivation of each group.
After excluding outliers, the large standard derivations are still troublesome. The average
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baseline in voice rest treatment group is almost double of those of the other two groups. But
we expect the same baselines for the three groups since we are dealing with the average data.
Therefore we need to normalize each data set individually. Each individual baseline has two
measurements, so the normalized factor is the average of the two. We shall fit the reduced
model to all treatment groups except the pre-inflamed group.
In Figure 30, before normalization, IL-1β peaks higher and later in spontaneous speech
group than the other two groups and it decreases faster with resonant voice than with voice
rest. The trajectories of IL-10 in the spontaneous speech group and resonant voice group are
almost the same and that in voice rest group never peaks - it decreases first and remains flat
all the time. In Figure 31, after normalization, we can see that IL-1β trajectories in each
group behave similarly as before, but the trajectory of IL-10 in spontaneous speech peaks
higher than in resonant voice at t = 22, and that in resonant voice IL-10 also has a small
peak. The normalized data set is more reasonable in a biological sense. The final normalized
data are in Table 1, 2, and 3.
Resonant has higher magnitude of vibration stress loading and lower magnitude of impact
stress loading than spontaneous. The IL-10 equation (3.2.14) mainly depends on IL-10 itself
and the vibration stress. It is hard for (3.2.14) to predict similar IL-10 trajectories of
spontaneous and resonant groups at the same time because of their different input vibration
stresses. Thus we updated our model again.
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Figure 31: Normalized data excluding the pre-inflamed patients and outliers. n is the number
of subjects in each group. The lines and bars represent the averages and standard derivations.
The second point is averaged over all valid data.
Time (hour) P (average) P (stand deviation) A (average) A (stand deviation)
0 1.00 0.34 1.00 0.14
1 1.03 0.65 1.14 0.68
6.5 1.91 1.41 1.64 0.66
22 8.07 5.16 2.61 1.78
Table 1: Normalized data for the spontaneous speech group
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Time (hour) P (average) P (stand deviation) A (average) A (stand deviation)
0 1.00 0.03 1.00 0.50
1 1.03 0.65 1.14 0.68
6.5 3.09 0.55 0.64 0.07
22 1.68 0.30 0.66 0.14
Table 2: Normalized data for the voice rest group
Time (hour) P (average) P (stand deviation) A (average) A (stand deviation)
0 1.00 0.17 1.00 0.11
1 1.03 0.65 1.14 0.68
6.5 4.17 3.52 1.22 0.39
22 0.62 0.39 2.01 1.69
Table 3: Normalized data for the resonant voice group
3.3 ODE MODEL
Because of the limited available data, we designed a reduced model that contains four
state variables representing the amount of tissue damage (D), activated inflammatory cells
(M), pro-inflammatory cytokines (P) and anti-inflammatory cytokines (A). The inflamma-
tory cells are represent macrophages, neutrophils or natural killer cells, pro-inflammatory
cytokines represent, for example, TNF-α or IL-1β, and the anti-inflammatory cytokines
represent IL-10. The influence diagram for the model is shown in Figure 32 .
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Figure 32: Model schema that illustrates the interactions between the four variables. The
plus indicates positive feedback and minus indicate negative feedback.
The model equations are here:
dD
dt
= αDII − P
2
α2DP + P
2
µDD (3.3.1)
dM
dt
= αMD(D + βP )− ε+ A
1 + αMAA
µMM (3.3.2)
dP
dt
=
αPMM(1 + αPV V )
1 + αAA2
(1 + αPDD)− µPP (3.3.3)
dA
dt
=
αAMM(1 + αPV V )
1 + (αA/γ)A2
P 2
α2AP + P
2
− µAA (3.3.4)
Tissue damage (D) is primarily created by impact stress (I) in the vocal fold [37, 38].
Experimental data show that the inflammatory response is mild. Therefore we neglect
secondary damage creation due to the presence of neutrophils that is prominent in some
published models of sepsis [48]. On the contrary, we assume that mild inflammation has a
beneficial effect of acceleration of healing of the damage, represented by a saturating term.
D together with pro-inflammatory cytokines (P) stimulates the activation of macrophages
(M) [59, 4, 79]. D also stimulates the production of P by M [19, 20]. M produce anti-
inflammatory cytokine (A) [11], that result in M deactivation [4, 5, 59] and inhibition of the
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M production of P [4, 79]. A also inhibits its own production a lesser degree than it inhibits
the production of P [17, 63], so the γ in equation (3.3.4) should be greater than one. The
production of A is stimulated by the presence of P through a sigmoidal function.
The prescribed dependence of V and I on time is determined by the experimental loading
schedule for the insult and the various treatments. In particular, we assume the loaded
impact stress I during the first hour screaming is 5 and the vibration stress V during that
period is 0. We take the values of vibratory stress during the spontaneous speech, voice rest
and resonant voice, respectively, to be 0, 0, and 1. Similarly, the values of impact stress
during those treatments were taken to be 1, 0 and 0 [85, 53]. The treatment duration is
between time 2.5h to 6.5h at the clinic and between 10h and 14h at patients’ home. The
values of model parameters were kept the same for all treatments.
3.3.1 Stability Analysis
In the absence of external input (i.e., if V and I are zero) and for small values of ε,
the ODE system has an unstable equilibrium at (D,M,P,A) = (0, 0, 0, 0) and a stable
equilibrium at (D,M,P,A) = (0, M¯ , P¯ , A¯), for which P¯ and A¯ are close to 1.
Steady state values of the system are solutions of the following system of equations:
0 =
P 2
α2DP + P
2
µDD (3.3.5)
0 = αMD(D + βP )− ε+ A
1 + αMAA
µMM (3.3.6)
0 =
αPMM
1 + αAA2
(1 + αPDD)− µPP (3.3.7)
0 =
αAMM
1 + (αA/γ)A2
P 2
α2AP + P
2
− µAA (3.3.8)
Equation (3.3.5) implies that P = 0 or D = 0. If P = 0, then the remaining equations
imply that M = 0, A = 0, and D = 0 and hence there is a zero equilibrium of the system
(D,M,P,A) = (0, 0, 0, 0). This equilibrium is unstable.
If D = 0, then M , P and A obey the following system:
0 = αMDβP − ε+ A
1 + αMAA
µMM (3.3.9)
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0 =
αPMM
1 + αAA2
− µPP (3.3.10)
0 =
αAMM
1 + (αA/γ)A2
P 2
α2AP + P
2
− µAA (3.3.11)
Equations (3.3.9) and (3.3.10) imply that the equilibrium value of A is equal to a root of the
following equation.
(ε+ A)(1 + αAA
2)− αMDβαPM
µMµP
(1 + αMAA) = 0 (3.3.12)
or
αAA
3 + εαAA
2 +
(
1− αMDβαPMαMA
µMµP
)
A+
(
ε− αMDβαPM
µMµP
)
= 0 (3.3.13)
According to the Routh criterion the number of non-negative roots is equal to the number
of sign changes in the left column of the array


αA 1− αMDβαPMαMAµMµP
εαA ε− αMDβαPMµMµP
αAαMDβαPM
µMµP
(
1−εαAαMA
εαA
)
0
αAαMDβαPM
µMµP
(
1−εαAαMA
εαA
)(
ε− αMDβαPM
µMµP
)
0


(3.3.14)
If ε is small enough, more precisely, if ε < min
(
1
αAαMA
, αMDβαPM
µMµP
)
, then the array has
precisely one change in sign, as the first three entries are positive and the last is negative.
Hence there is one positive solution for A. Equations (3.3.9) and (3.3.10) imply that M and
P have the same sign in equilibrium and (3.3.11) implies that M and A have the same sign.
Thus, for small ε there is a single positive equilibrium (D,M,P,A) = (0, M¯ , P¯ , A¯), which is
linearly stable.
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3.3.2 Parameter Estimation
Parameter values were estimated using both traditional maximum likelihood optimiza-
tion and also using a novel method of ensemble modeling. Traditional parameter fitting
methodology is based on the assumption that all experimental subjects can be described by
the same set of parameters and that random noise leads to differences between the measured
values of state variables. By taking averages over multiple subjects, one can recover the
true value of the variable and then optimize the parameters of the model so that the model
predicts the true values.
3.3.2.1 Objective Function in the Optimization The first step of model fitting is to
optimize parameter values over all three treatment scenarios simultaneously. The objective
function F reflects the difference between model prediction and the available data. Two
versions were considered - one in which the mean square differences were weighted by the
variance of the data and another in which all data were taken with equal weights. Calibration
with the first choice of function led to an unresponsive model with flat configurations, which
is why we gave preference to the second choice:
The objective function used in the optimization is constructed in the following way:
F =
3∑
j=1
4∑
i=1
(
yPij − y˜Pij
)2
+
3∑
j=1
4∑
i=1
(
yAij − y˜Aij
)2
+
3∑
j=1
(M0,j −M0)2
+
3∑
j=1
(
Dmax,j −D
)2
+
3∑
j=1
(Dend,j)
2 (3.3.15)
In the objective function (3.3.15) the index j represents the summation over the data in
three treatments and the index i represents summation over the four time points. yPi and
yAi are the simulated data computed from the trajectory of the model, while y˜
P
i and y˜
A
i are
observed data from the experiment - the normalized data that we discussed in last section.
Since we have normalized the data by individual baseline, the starting values of P and A
are 1. Similarly, M also has an initial baseline to start with, which we define as M0 with
value 1. The initial value of damage is 0. As additional heuristic criteria we have included
the final value of the damage Dend,j (assumed to be zero as in a successful healing process)
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and the maximum value of the damage Dmax,j to be an arbitrary value D in order to fix the
scale of that variable. The value D is assumed to be the same over different treatments as
the treatments are not expected to add additional damage to the system after the first hour.
To find the set of parameters that minimize (3.3.15) we use an iterative optimization
algorithm. For each set of parameters, we find the corresponding equilibrium value and then
use it as the initial value for integration of the system. The resulting trajectory is the used to
compute yPi and y
A
i . This way we can make sure that the optimal model has an equilibrium
point close to the homeostatic level. The data used for fitting are shown in Table 1, 2, and
3.
3.3.2.2 Ensemble Model Ensemble modeling replaces a traditional, uniquely parame-
terized model with an ensemble of models that vary in parameter values and possibly the
model structure. Each model in the ensemble is assigned a probability value that correlates
with the likelihood that the model agrees with given data and heuristic constraints. In this
way the ensemble of models summarizes uncertainties in parameter values, sensitivity of the
model, and the completeness of the data in a single distribution.
One way to interpret the ensemble model is by treating it as a representation of popu-
lation heterogeneity of parameter values, i.e., the fact that parameters may be distinct for
different individuals in the population.
The main benefit of ensemble model is that any predictions made using the model is
probabilistic, resulting from all models compatible with the data but with larger weight
coming from more accurate models. Therefore, for each such a prediction one can determine
the interval of confidence.
The idea of ensemble modeling was first introduced in weather prediction but has recently
been applied also to biological models. The most common ensemble modeling method con-
structs the ensemble by fixing the structure of the model (i.e., the set of differential equations
and definitions of the parameters) and then computes the probability density ρ(α) of a pa-
rameter set α with the likelihood L(α) of observing the data with that model. The likelihood
function depends on the amount and quality of experimental data. The probability density
is computed using Bayesian approach as ρ(α) = Q−1L(α)θ(α), where Q =
∫
L(α)θ(α)dα is
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a normalizing constant and θ(α) is the prior distribution containing information about the
range of parameter values that is biologically acceptable. Here we sample Gibbs-Boltzman
distribution ρ(α) = exp(−βF (α)), where F (α) is the objective function corresponding to
the parameter set α and β is the reciprocal of temperature value T. We choose θ(α) for
each parameter to be a uniform distribution roughly between 1/20 and 20 times the baseline
value. Table 4 shows the baseline, prior range, and the average and standard deviation for
each parameter. We choose αi to represent the logarithm of the value of the correspond-
ing parameter (i.e., α1 = logαDI , α2 = log µD) rather than the parameter itself for several
reasons: (i) trajectories of a system of ODEs are sensitive to relative, rather than absolute
changes in parameters, (ii) the parameters are always positive and (iii) we wish to avoid
biasing the sample toward large values of the parameters. This choice does not affect the
principles of the ensemble modeling, only the sampling metric on the parameter space.
More discussion about ensemble methods can be found in Hancioglu’s PhD thesis [39].
Metropolis Sampling
The easiest way to represent the distribution ρ(α) is by a sample of points α1,..., αM
distributed according to ρ(α). The sample can be used to estimate the ensemble average of
any trajectory-dependent quantity H as
< H > ∼= M−1
∑M
i=1
H(x(t;αi,x0)) (3.3.16)
The percentile value PX(H) of any trajectory-dependent quantity H can be found as the
smallest number that is larger than X% of values H(x(t;αi,x0)), i = 1, ...,M .
The Metropolis-Hastings Markov Chain (MHMC) sampling algorithm is a Monte Carlo
method for finding a sample α1,..., αM for any distribution defined as ρ(α) = exp(−βE(α))
[62, 41]. The original MHMC method samples the distribution at a fixed value of β by
proposing, at every step k, a random perturbation α¯ of the current parameter set αk and
accepting this perturbed set as the next set in the sample, i.e., αk+1, with the probability
P = min{1, exp (−β (E(α¯)−E(αk)))}. If α¯ is rejected then αk+1 is set equal to αk. In
other words, if the proposed move is associated with a reduction of the objective function,
thus a likelihood ratio > 1, the move is accepted. Yet, if the likelihood ratio is < 1, there
is still a probability < 1 that the move is accepted, allowing the possibility of the chain to
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escape local minima. The resulting sequence αk is a Markov Chain that has a stationary
probability distribution that converges to ρ(α) in the limit of large k.
In our case, we define the objective function (3.3.15) as an energy function E and sample
Gibbs-Boltzmann distribution through ρ(α) = exp (−βE(α)). The algorithm starts at some
random initial guess of parameters, and then let these parameters jump to its neighborhood.
Calculate the energy function of the two parameters set. If the new energy is smaller than the
old one, then the new parameter set is accepted with probability 1, otherwise it is accepted
with a probability, which is equal to the log likelihood ratio. A random number is generated
from the uniform distribution on zero to one each step and compared with the log likelihood
ratio. If the number is greater than that ratio, then the move is accepted, otherwise, it is
rejected. When the number of sampling steps goes to infinity, the probability of parameters
values converges to an equilibrium probability distribution, which is independent of the initial
parameter values [27].
The algorithm is below [39]:
• Construct the energy function E.
• Start at some random initial guess of parameter set α1 and calculate the value of the
energy function E as E1 at α1.
• Generate a new parameter set α¯ through the formula α¯ = α1exp (−εrn). ε is a constant
associated with the temperature T = 1/β, rn is a rand number generated by the standard
normal distribution.
• Calculate the energyEb at α¯ and accept α¯ with a probability of P = min (1, exp (−β(Eb − E1))).
• If Y is accepted, then assign α2 = α¯ and E2 = Eb, else α2 = α1 and E2 = E1.
• Repeat from step 3. Adjust the ε value to get the acceptance rate around 30%.
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Figure 33: Schematic representation of the Metropolis sampling algorithm.
Parallel Tempering
Unlike Metropolis sampling, which is consisted of a single Markov chain at one partic-
ular temperature value, parallel tempering algorithm generates multiple versions αk,i of the
Markov Chain evaluated at different temperature values (i.e., different β). At high tempera-
ture (low β), the parameters have a bigger step size so that they can explore a larger region
of the phase space. At low temperature, the parameters are more precisely sampled in a local
region [25]. Every once in a while the parameter sets αk,i and αk,i+1 in two neighboring values
βi and βi+1 are swapped with probability P = min{1, exp([βi − βi+1][E(αk,i)−E(αk,i+1)])}.
Therefore, using parallel tempering the algorithm can explore larger phase space and con-
verge faster to a stationary probability distribution by improving chain mixing.
We construct 4 replicas with β1, β2, β3 and β4 equals to 1, 0.5, 0.25 and 0.125, respectively.
Optimal convergence of parallel tempering MHMC is achieved if the acceptance ratio (i.e,
the ratio of accepted to proposed sets) has a specified value. Rathore et al. suggested that
the optimal acceptance ration of each replica is 20% to yield the best performance, Kone
et al. suggested this ratio to be 23% [25], while Feller W. suggested it in the range of 30%
to 40% [27]. In our simulation, the accepted ratios of each replica are 30.2%, 30.6%, 30.9%
and 31.3%. The ε values, a measure of the proposed steps in the procedure are chosen as
0.071, 0.108, 0.162 and 0.249 of each replica. The chain with β = 1 provides the Boltzmann
sample. The swapping acceptance rate between replica 1 & 2, 2 & 3, 3 & 4 are 26.0%, 28.3%,
37.5%.
The algorithm we use is as follows:
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• Construct 4 replicas by using Metropolis sampling based on different temperature values.
• Run the basic Metropolis algorithm for each replica five steps. Five is chosen to give a
reasonable swapping rate, therefore to provide a good mixing.
• Perform swaps between adjacent replicas with a probability of P = min{1, exp([βi −
βi+1][E(α
k,i)− E(αk,i+1)])}, where βi > βi+1
• Repeat from step 2.
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Figure 34: Schematic representation of the Parallel-Tempering algorithm.
3.3.3 Sensitivity Analysis and Parameter Reduction
The sensitivity analysis reveals the robustness of the model by exploring to which pa-
rameters the trajectory of system is most sensitive. One can use the results to reduce the
number of parameters in the model.
The model (3.3.1) ∼ (3.3.4) has 4 equations with 4 states (D,M,P,A) and 17 parameters
(θ). Since we only have data of P and A, so we only consider sensitivities at those two
equations. The 2×17 sensitivity matrix S = (sij) is defined below. The sensitivity coefficients
sij are calculated from the difference of nominal and perturbed solutions [16].
sij(t) =
∂xi(t)
∂θj
=
xi(θj +∆θj , t)− xi(θj , t)
∆θj
(3.3.17)
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Here i ∈ [1, 2] and j ∈ [1, 17]. Since the states and parameters have different magnitudes,
in order to facilitate the comparison of parameter sensitivities, we normalized sij in the
following way [16]:
s¯ij =
∂xi(t)
∂θj
θj
xi
(3.3.18)
Calculate the normalized sensitivity matrix S¯(t) at 4 data points. The matrix G is con-
structed in the following way:
G =


S¯(t1)
S¯(t2)
S¯(t3)
S¯(t4)


(3.3.19)
We calculate the G matrices over 2,000 parameter samples evenly chosen from samples
generated by parallel tempering and take the average over all these G matrices to get a new
matrix G =
∑n
i=1Gi. Then calculate the covariance matrix C, where C(i, j) is the covariance
of the ith and jth column of G¯. By sorting the diagonal elements of matrix C, we can find
the most to least sensitive parameters. Since some of the parameters are highly correlated,
we need to check the covariance coefficient matrix R, which R(i, j) = C(i,j)√
C(i,i)C(i,j)
. If some
pair of the parameters are highly correlated with each other, then we only need to pick one
of them. Here is the algorithm to pick the reduced parameter set.
• Calculate the sensitivity matrices G over the parameter sets got from parallel tempering.
• Calculate the averaged sensitivity matrix G =∑ni=1Gi.
• Calculate the covariance matrix C of G¯ and sort the diagonal elements of C. Then we
have the sensitive parameters in order.
• Start from the most sensitive parameter i, and check its covariance coefficients R(i, j)
with others. Exclude the parameters which are highly correlated with i. And then repeat
this procedure to the next sensitive parameter if it has not been excluded yet.
3.3.4 Individual Fit
In the sensitivity analysis, we determine parameters to which the model is the most
sensitive. We perform parameter fitting for individuals by minimize the objective function
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over the sensitive parameters while fixing the other parameters at the average values of the
marginal distributions obtained from parallel sampling.
3.3.5 ODE Model Results
All the numerical results are simulated in MATLAB 7.5.0 (R2007b). The collected data
are shown in Figure 30 after elimination of outliers (defined as isolated values outside of
3 standard deviations for each data point). The lines and bars represent the average and
standard derivation of each group.
From the data one can see that IL-10 is quite flat during the observation period of any
group. Since the baseline values varied over an order of magnitude, we re-normalized the
data by dividing data for each subject by that subjects average base-line values (at the first
time point). Normalized data are shown in Figure 31. In that figure, the average at the
first and second time points is averaged over all patient data at that time point because
all patients to the same conditions up to the point, no matter which treatment group they
belong to.
There are statistically significant differences between the trajectory of spontaneous speech
and the trajectories of the other two treatments. Much less difference can be observed
between voice rest and resonant voice treatment. Spontaneous speech appears to lead to
a high level of inflammation at the end of the 24hr period. Voice rest and resonant voice
treatments have IL1-β levels that peak in the middle of the treatment period and then return
to the baseline by 24hr. The peak for resonant voice is slightly larger but with larger variance
as well. IL-10 levels rise during treatment phase for both spontaneous speech and resonant
voice treatments but not for voice rest treatment.
To explain the data we hypothesize that spontaneous speech increases damage in the sys-
tem by producing moderate levels of impact stress. The additional damage leads to increased
levels of pro-inflammatories for that treatment. We further hypothesize that resonant voice
produces large amount of vibratory stress that increases the production of both inflamma-
tory cytokines by macrophages. We have utilized these hypotheses in the construction of
the model and then set out to validate those hypotheses by fitting the model to the data.
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The optimal parameter fit, based on minimization of the objective function (3.3.15), can
be seen in Figure 35. The last column of Table 4 shows the parameter values represented
in that figure. The trajectory of the system fits most of the data points. The exception is
the level of IL-10 in the voice-rest treatment case that is predicted 3 times larger than the
experimental values. The trajectory for macrophages is compatible with mild inflammation,
resulting in up to 3 fold activation of macrophages (for spontaneous speech). The trajectory
for damage is almost identical for voice rest and resonant voice treatments.
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Figure 35: Optimal parameter fit for the model. The parameter values are showed in the
last column of Table 4.
3.3.5.1 Ensemble Method Table 4 shows the baseline, prior range, average and stan-
dard deviation for each parameter.
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No Parameter Baseline Range Average SD Sample
1 αDI 0.86 0.043 ∼ 17.2 0.7631 0.1172 0.8420
2 αDP 0.53 0.0265 ∼ 10.6 0.3194 0.3974 0.1338
3 µD 0.18 0.009 ∼ 3.6 0.133 0.0681 0.1555
4 αMD 0.05 0.0025 ∼ 1 0.0566 0.0943 0.0339
5 β 1.8 0.01 ∼ 10 2.5262 2.5955 5.4937
6 ε 0.1 0.005 ∼ 1 0.1239 0.1537 0.0069
7 αMA 3.4 0.17 ∼ 68 11.7458 15.6568 6.6537
8 µM 0.3 0.015 ∼ 6 0.3912 0.7383 1.2744
9 αPM 0.17 0.085 ∼ 3.4 0.4534 0.5541 0.1988
10 αPD 1.3 0.065 ∼ 26 4.8495 4.3919 1.6785
11 αPV 1 0.05 ∼ 20 0.8571 0.8845 0.5789
12 αA 1.5 0.075 ∼ 30 8.0904 8.2102 1.6323
13 µP 0.14 0.025 ∼ 0.5 0.1037 0.0628 0.0896
14 αAM 0.1 0.025 ∼ 10 1.7211 2.0583 0.1735
15 γ 4 1 ∼ 10 2.9009 2.0393 1.7598
16 αAP 2.7 0.2 ∼ 4 0.4386 0.2520 0.2022
17 µA 0.1 0.05 ∼ 1 0.2909 0.2524 0.0682
Table 4: Baseline, prior range, average and standard deviation of each parameter
We have performed 4 distinct runs starting from randomly initial parameter values by
the Metropolis Monte Carlo algorithm. The length of each run is 320,000, 320,000, 320,000
and 90,000 after discarding the initial points (burn-in-period) from each run. In order to
lower the autocorrelation, the samples are stored every 5th point. The convergence of each
run is tested using Gelman and Rubin diagnostic [28], which calculates a potential scale
reduction factor associated with each parameter. That factor values in our model are all
below 1.01 which is within the confidence interval.
We have combined all stored samples of 210,000 points for further analysis. Marginal
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parameter distributions are shown in Figure 36. 14 parameters have peaks within the prior
distribution range, while the remaining distributions are skewed.
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Figure 36: Marginal parameter distributions for the ensemble model. The X-axis is in log10
scale.
The trajectory statistics for the ensemble model is shown in Figure 37 as not as individual
trajectories, but as percentile levels of the distribution of the variable versus time. For
example, if the 75th percentile curve of A has value A0 at time t0, then 75% of all trajectories
in the ensemble have A(t0) 6 A0. As see in Figure 37, the variances in the values of both
pro- and anti-inflammatories are approximately constant in time. The large increase in the
variance of M is a result of having no constraint on the maximum value of M. Again, the
distributions reflect the inability of the model to capture the decrease in IL-10 for the voice
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rest treatment.
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Figure 37: Trajectory statistics of the ensemble model. For each variable, the percentile
of the resulting distribution is shown at each time point: 95th percentile (top green), 75th
percentile (top blue), 50th percentile (red), 25th percentile (bottom blue), and 5th percentile
(bottom green).
3.3.5.2 Sensitivity Analysis and Parameter Reduction By sorting the diagonal
elements of the covariance matrix C of G¯, we have the most to the least sensitive parameter
in the following order: 1, 9, 3, 17, 14, 10, 13, 4, 15, 12, 5, 8, 7, 16, 2, 11, 6. We assume that
two parameters are highly correlated if their absolute value of the covariance coefficient is
great than 0.95. Parameter 1 is the most sensitive one - it is highly correlated with 9 and
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10; go to the next most sensitive parameter - 3 is highly correlated with 2 and 13; go to next
sensitive parameter - 17 is highly correlated with 14, 15, and 16; then parameter 4 is highly
correlated with parameter 5 and 12; then parameter 8 is highly correlated with 8; and 11 is
not highly correlated with any of the others. So the reduced parameter set are: 1, 3, 4, 8, 11
and 17, corresponding to αDI , µD, αMD, µM , αPV and µA. We have also tried the singular
value decomposition to calculate the sensitivities, but it doesn’t perform as good as this one.
The sensitivity-dependent correlation matrix correlation containing the correlation coef-
ficients of the 17 parameters is in Figure 38. Red represents positive highly correlated, blue
represents negative highly correlated, and the other colors are the intermediate ones.
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Figure 38: Correlation coefficient matrix. The red color means highly positive correlated
and the blue color means highly negative correlated.
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3.3.5.3 Pre-inflamed Group We mentioned before that there are two patients who
received the treatment in voice rest having high initial value of IL-1β. These two patients
are defined as pre-inflamed ones. The baseline values of IL-1β and IL-10 are normalized by
the average of other two patients’ baselines in voice rest group. The initial value of this
group is (D,M,P,A) = (0, 1, 11.33, 0.76). The full parameter sets got from the sampling
method above are applied to the pre-inflamed group. We also run the statistical trajectories
of this group.
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Figure 39: Trajectory statistics of the ensemble model of the pre-inflamed group which only
received treatment in voice rest. For each variable the percentile of the resulting distribution
is shown at each time point: 95th percentile (top green), 75th percentile (top blue), 50th
percentile (red), 25th percentile (bottom blue), and 5th percentile (bottom green).
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The two patients in the pre-inflamed group received the treatment of voice rest. Data
points of IL-1β and IL-10 in Figure 39 are all measured under the treatment of voice rest. The
damage behaviors of the pre-inflamed patients are almost the same as those of the normal
patients. Thus we could see that pre-inflammation would not cause extra damage during
the phonation loading. The magnitudes of macrophage, IL-1β and IL-10 in pre-inflamed
patients are much higher than the normal patients in corresponding treatment group. IL-1β
has small peak in spontaneous and decreases almost consistently in the other two treatments.
The IL-10 increases in all three treatments and peaks at similar levels. From the statistical
trajectory, we can see that the best therapy to heal from vocal fold inflammation for those
pre-inflamed people is also voice rest or treatment in resonant voice.
3.3.5.4 Individual Fit and prediction There is one special subject who receives the
3 different treatments at different time. We fit this one through the reduced parameter set.
We only input the data of first three time points and try to predict the last one. Figure 40
shows one of the optimal fits.
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Figure 40: Optimal parameter fit and prediction for individual. The parameter values are
showed in the last column of Table 5.
In spontaneous, the model tries to predict the peak of IL-1β. The predicted peak time
is right but the magnitude is not as high as the real data. Though the second point of
IL-10 is not assimilated in the model, but the peak of IL-10 is predicted. In voice rest, the
model assimilates the first three data points of IL-1β very well and the prediction of the
fourth agrees with the real data point. For the IL-10, again, the model hasn’t captured the
decrease of IL-10. In the resonant voice, the model’s assimilation and prediction of IL-1β is
not perfect, but acceptable. Then again, the decrease of IL-10 is not captured.
Parameter values in Figure 40 are showed in the last column of Table 5. Parameters in red
are the new optimal values of the reduced set and black are the fixed less sensitive parameters
95
obtained from the average in parallel samplings. Table 5 also lists the average and standard
derivation of parameters in parallel sampling. We can see except one parameter αPV , all the
other new optimal parameter values are within the standard derivation of the average values
in the full model. αPV is an exception might because this parameter characterizes the effect
vibration stress in pro- and anti-inflammatories. Each individual may react quite differently
to a same treatment therapy.
No Parameter Average SD Optimal
1 αDI 0.7631 0.1172 0.9474
2 αDP 0.3194 0.3974 0.3194
3 µD 0.133 0.0681 0.1213
4 αMD 0.0566 0.0943 0.0288
5 β 2.5262 2.5955 2.5262
6 ε 0.1239 0.1537 0.1239
7 αMA 11.7458 15.6568 11.7458
8 µM 0.3912 0.7383 0.3479
9 αPM 0.4534 0.5541 0.4534
10 αPD 4.8495 4.3919 4.8495
11 αPV 0.8571 0.8845 8.1921
12 αA 8.0904 8.2102 8.0904
13 µP 0.1037 0.0628 0.1037
14 αAM 1.7211 2.0583 1.7211
15 γ 2.9009 2.0393 2.9009
16 αAP 0.4386 0.2520 0.4386
17 µA 0.2909 0.2524 0.0953
Table 5: Parameters in red are the new optimal values of the reduced set and black are the
fixed parameters obtained from the averages of the whole parameter set in parallel samplings.
The values in the other two columns are average and standard derivation of each parameter
in parallel sampling.
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3.4 CONCLUSION
We have employed mathematical modeling to explain differences in trajectories of pa-
tients with vocal fold inflammation subject to individualized treatments. We have designed
an ensemble model representing the parameter variability of the patient population and
found that it mostly agrees with the data. We conducted the sensitivity analysis in order
to find the global and local parameters and then fix the global parameters and optimize the
local ones for individuals. The model was not very successful in fitting to individual patients
trajectories.
The first limitation of this model is that it is simplified to only 4 variables. More com-
plex models can be constructed, but ultimately, the limited data set and the high variance
restricted our ability to fit such models. The inclusion of the fibroblast and collagen into
the model will result in a better understanding of the healing process. The second limita-
tion of the current model is its simplified account of the loading conditions, represented by
vibratory or impact stress variables. We need to have a more qualitative understanding of
the magnitude and effect of the two stresses. The third limitation is the fact that since our
reduction methods resulted in missing IL-10 trajectories, rather than isolated data points,
it might be more appropriate to adopt global methods, rather than local methods in this
situation. Such methods typically results is less parsimonious reduction in the number of
parameters and thus greater ability to fit data.
Our future goal is to develop a method for proposing a patient specific vocal exercise
schedule or rest program that optimizes tissue healing in cases of both acute and chronic
phonotrauma.
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